<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2019-03-02T20:02:42Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:5069600" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:5069600</identifier><datestamp>2016-11-01</datestamp><setSpec>blackwellopen</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Ann Neurol</journal-id>
      <journal-id journal-id-type="iso-abbrev">Ann. Neurol</journal-id>
      <journal-id journal-id-type="doi">10.1002/(ISSN)1531-8249</journal-id>
      <journal-id journal-id-type="publisher-id">ANA</journal-id>
      <journal-title-group>
        <journal-title>Annals of Neurology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0364-5134</issn>
      <issn pub-type="epub">1531-8249</issn>
      <publisher>
        <publisher-name>John Wiley and Sons Inc.</publisher-name>
        <publisher-loc>Hoboken</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC5069600</article-id>
      <article-id pub-id-type="pmcid">PMC5069600</article-id>
      <article-id pub-id-type="pmc-uid">5069600</article-id>
      <article-id pub-id-type="pmid">26991897</article-id>
      <article-id pub-id-type="doi">10.1002/ana.24612</article-id>
      <article-id pub-id-type="publisher-id">ANA24612</article-id>
      <article-categories>
        <subj-group subj-group-type="overline">
          <subject>Research Article</subject>
        </subj-group>
        <subj-group subj-group-type="heading">
          <subject>Research Articles</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Mutations in <italic>MME</italic> cause an autosomalârecessive CharcotâMarieâTooth disease type 2</article-title>
        <alt-title alt-title-type="right-running-head">Mutations in <italic>MME</italic> Cause ARâCMT2</alt-title>
        <alt-title alt-title-type="left-running-head">Higuchi et al</alt-title>
      </title-group>
      <contrib-group>
        <contrib id="ana24612-cr-0001" contrib-type="author">
          <name>
            <surname>Higuchi</surname>
            <given-names>Yujiro</given-names>
          </name>
          <degrees>MD</degrees>
          <xref ref-type="aff" rid="ana24612-aff-0001">
<sup>1</sup>
</xref>
        </contrib>
        <contrib id="ana24612-cr-0002" contrib-type="author">
          <name>
            <surname>Hashiguchi</surname>
            <given-names>Akihiro</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <xref ref-type="aff" rid="ana24612-aff-0001">
<sup>1</sup>
</xref>
        </contrib>
        <contrib id="ana24612-cr-0003" contrib-type="author">
          <name>
            <surname>Yuan</surname>
            <given-names>Junhui</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <xref ref-type="aff" rid="ana24612-aff-0001">
<sup>1</sup>
</xref>
        </contrib>
        <contrib id="ana24612-cr-0004" contrib-type="author">
          <name>
            <surname>Yoshimura</surname>
            <given-names>Akiko</given-names>
          </name>
          <degrees>MPAS</degrees>
          <xref ref-type="aff" rid="ana24612-aff-0001">
<sup>1</sup>
</xref>
        </contrib>
        <contrib id="ana24612-cr-0005" contrib-type="author">
          <name>
            <surname>Mitsui</surname>
            <given-names>Jun</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <xref ref-type="aff" rid="ana24612-aff-0002">
<sup>2</sup>
</xref>
        </contrib>
        <contrib id="ana24612-cr-0006" contrib-type="author">
          <name>
            <surname>Ishiura</surname>
            <given-names>Hiroyuki</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <xref ref-type="aff" rid="ana24612-aff-0002">
<sup>2</sup>
</xref>
        </contrib>
        <contrib id="ana24612-cr-0007" contrib-type="author">
          <name>
            <surname>Tanaka</surname>
            <given-names>Masaki</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <xref ref-type="aff" rid="ana24612-aff-0002">
<sup>2</sup>
</xref>
        </contrib>
        <contrib id="ana24612-cr-0008" contrib-type="author">
          <name>
            <surname>Ishihara</surname>
            <given-names>Satoshi</given-names>
          </name>
          <degrees>MD</degrees>
          <xref ref-type="aff" rid="ana24612-aff-0001">
<sup>1</sup>
</xref>
          <xref ref-type="aff" rid="ana24612-aff-0003">
<sup>3</sup>
</xref>
        </contrib>
        <contrib id="ana24612-cr-0009" contrib-type="author">
          <name>
            <surname>Tanabe</surname>
            <given-names>Hajime</given-names>
          </name>
          <degrees>MD</degrees>
          <xref ref-type="aff" rid="ana24612-aff-0001">
<sup>1</sup>
</xref>
        </contrib>
        <contrib id="ana24612-cr-0010" contrib-type="author">
          <name>
            <surname>Nozuma</surname>
            <given-names>Satoshi</given-names>
          </name>
          <degrees>MD</degrees>
          <xref ref-type="aff" rid="ana24612-aff-0001">
<sup>1</sup>
</xref>
        </contrib>
        <contrib id="ana24612-cr-0011" contrib-type="author">
          <name>
            <surname>Okamoto</surname>
            <given-names>Yuji</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <xref ref-type="aff" rid="ana24612-aff-0001">
<sup>1</sup>
</xref>
        </contrib>
        <contrib id="ana24612-cr-0012" contrib-type="author">
          <name>
            <surname>Matsuura</surname>
            <given-names>Eiji</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <xref ref-type="aff" rid="ana24612-aff-0001">
<sup>1</sup>
</xref>
        </contrib>
        <contrib id="ana24612-cr-0013" contrib-type="author">
          <name>
            <surname>Ohkubo</surname>
            <given-names>Ryuichi</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <xref ref-type="aff" rid="ana24612-aff-0001">
<sup>1</sup>
</xref>
          <xref ref-type="aff" rid="ana24612-aff-0004">
<sup>4</sup>
</xref>
        </contrib>
        <contrib id="ana24612-cr-0014" contrib-type="author">
          <name>
            <surname>Inamizu</surname>
            <given-names>Saeko</given-names>
          </name>
          <degrees>MD</degrees>
          <xref ref-type="aff" rid="ana24612-aff-0005">
<sup>5</sup>
</xref>
        </contrib>
        <contrib id="ana24612-cr-0015" contrib-type="author">
          <name>
            <surname>Shiraishi</surname>
            <given-names>Wataru</given-names>
          </name>
          <degrees>MD</degrees>
          <xref ref-type="aff" rid="ana24612-aff-0005">
<sup>5</sup>
</xref>
        </contrib>
        <contrib id="ana24612-cr-0016" contrib-type="author">
          <name>
            <surname>Yamasaki</surname>
            <given-names>Ryo</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <xref ref-type="aff" rid="ana24612-aff-0005">
<sup>5</sup>
</xref>
        </contrib>
        <contrib id="ana24612-cr-0017" contrib-type="author">
          <name>
            <surname>Ohyagi</surname>
            <given-names>Yasumasa</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <xref ref-type="aff" rid="ana24612-aff-0005">
<sup>5</sup>
</xref>
        </contrib>
        <contrib id="ana24612-cr-0018" contrib-type="author">
          <name>
            <surname>Kira</surname>
            <given-names>Junâichi</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <xref ref-type="aff" rid="ana24612-aff-0005">
<sup>5</sup>
</xref>
        </contrib>
        <contrib id="ana24612-cr-0019" contrib-type="author">
          <name>
            <surname>Oya</surname>
            <given-names>Yasushi</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <xref ref-type="aff" rid="ana24612-aff-0006">
<sup>6</sup>
</xref>
        </contrib>
        <contrib id="ana24612-cr-0020" contrib-type="author">
          <name>
            <surname>Yabe</surname>
            <given-names>Hayato</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <xref ref-type="aff" rid="ana24612-aff-0007">
<sup>7</sup>
</xref>
        </contrib>
        <contrib id="ana24612-cr-0021" contrib-type="author">
          <name>
            <surname>Nishikawa</surname>
            <given-names>Noriko</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <xref ref-type="aff" rid="ana24612-aff-0007">
<sup>7</sup>
</xref>
        </contrib>
        <contrib id="ana24612-cr-0022" contrib-type="author">
          <name>
            <surname>Tobisawa</surname>
            <given-names>Shinsuke</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <xref ref-type="aff" rid="ana24612-aff-0008">
<sup>8</sup>
</xref>
        </contrib>
        <contrib id="ana24612-cr-0023" contrib-type="author">
          <name>
            <surname>Matsuda</surname>
            <given-names>Nozomu</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <xref ref-type="aff" rid="ana24612-aff-0009">
<sup>9</sup>
</xref>
        </contrib>
        <contrib id="ana24612-cr-0024" contrib-type="author">
          <name>
            <surname>Masuda</surname>
            <given-names>Masayuki</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <xref ref-type="aff" rid="ana24612-aff-0010">
<sup>10</sup>
</xref>
        </contrib>
        <contrib id="ana24612-cr-0025" contrib-type="author">
          <name>
            <surname>Kugimoto</surname>
            <given-names>Chiharu</given-names>
          </name>
          <degrees>MD</degrees>
          <xref ref-type="aff" rid="ana24612-aff-0011">
<sup>11</sup>
</xref>
        </contrib>
        <contrib id="ana24612-cr-0026" contrib-type="author">
          <name>
            <surname>Fukushima</surname>
            <given-names>Kazuhiro</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <xref ref-type="aff" rid="ana24612-aff-0012">
<sup>12</sup>
</xref>
        </contrib>
        <contrib id="ana24612-cr-0027" contrib-type="author">
          <name>
            <surname>Yano</surname>
            <given-names>Satoshi</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <xref ref-type="aff" rid="ana24612-aff-0013">
<sup>13</sup>
</xref>
        </contrib>
        <contrib id="ana24612-cr-0028" contrib-type="author">
          <name>
            <surname>Yoshimura</surname>
            <given-names>Jun</given-names>
          </name>
          <degrees>PhD</degrees>
          <xref ref-type="aff" rid="ana24612-aff-0014">
<sup>14</sup>
</xref>
        </contrib>
        <contrib id="ana24612-cr-0029" contrib-type="author">
          <name>
            <surname>Doi</surname>
            <given-names>Koichiro</given-names>
          </name>
          <degrees>PhD</degrees>
          <xref ref-type="aff" rid="ana24612-aff-0014">
<sup>14</sup>
</xref>
        </contrib>
        <contrib id="ana24612-cr-0030" contrib-type="author">
          <name>
            <surname>Nakagawa</surname>
            <given-names>Masanori</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <xref ref-type="aff" rid="ana24612-aff-0015">
<sup>15</sup>
</xref>
        </contrib>
        <contrib id="ana24612-cr-0031" contrib-type="author">
          <name>
            <surname>Morishita</surname>
            <given-names>Shinichi</given-names>
          </name>
          <degrees>PhD</degrees>
          <xref ref-type="aff" rid="ana24612-aff-0014">
<sup>14</sup>
</xref>
        </contrib>
        <contrib id="ana24612-cr-0032" contrib-type="author">
          <name>
            <surname>Tsuji</surname>
            <given-names>Shoji</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <xref ref-type="aff" rid="ana24612-aff-0002">
<sup>2</sup>
</xref>
        </contrib>
        <contrib id="ana24612-cr-0033" contrib-type="author" corresp="yes">
          <name>
            <surname>Takashima</surname>
            <given-names>Hiroshi</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <xref ref-type="aff" rid="ana24612-aff-0001">
<sup>1</sup>
</xref>
        </contrib>
      </contrib-group>
      <aff id="ana24612-aff-0001">
        <label>
          <sup>1</sup>
        </label>
        <named-content content-type="organisation-division">Department of Neurology and Geriatrics</named-content>
        <institution>Kagoshima University Graduate School of Medical and Dental Sciences</institution>
        <named-content content-type="city">Kagoshima</named-content>
        <country country="JP">Japan</country>
      </aff>
      <aff id="ana24612-aff-0002">
        <label>
          <sup>2</sup>
        </label>
        <named-content content-type="organisation-division">Department of Neurology, Graduate School of Medicine</named-content>
        <institution>The University of Tokyo</institution>
        <named-content content-type="city">Tokyo</named-content>
        <country country="JP">Japan</country>
      </aff>
      <aff id="ana24612-aff-0003">
        <label>
          <sup>3</sup>
        </label>
        <named-content content-type="organisation-division">Department of Cardiovascular medicine, Nephrology and Neurology, Graduate School of Medicine</named-content>
        <institution>University of the Ryukyus</institution>
        <named-content content-type="city">Okinawa</named-content>
        <country country="JP">Japan</country>
      </aff>
      <aff id="ana24612-aff-0004">
        <label>
          <sup>4</sup>
        </label>
        <named-content content-type="organisation-division">Department of Neurology</named-content>
        <institution>Fujimoto General Hospital</institution>
        <named-content content-type="city">Miyazaki</named-content>
        <country country="JP">Japan</country>
      </aff>
      <aff id="ana24612-aff-0005">
        <label>
          <sup>5</sup>
        </label>
        <named-content content-type="organisation-division">Department of Neurology, Neurological Institute, Graduate School of Medical Sciences</named-content>
        <institution>Kyushu University</institution>
        <named-content content-type="city">Fukuoka</named-content>
        <country country="JP">Japan</country>
      </aff>
      <aff id="ana24612-aff-0006">
        <label>
          <sup>6</sup>
        </label>
        <named-content content-type="organisation-division">Department of Neurology, National Center Hospital</named-content>
        <institution>National Center of Neurology and Psychiatry</institution>
        <named-content content-type="city">Tokyo</named-content>
        <country country="JP">Japan</country>
      </aff>
      <aff id="ana24612-aff-0007">
        <label>
          <sup>7</sup>
        </label>
        <named-content content-type="organisation-division">Department of Neurology and Clinical Pharmacology</named-content>
        <institution>Ehime University Graduate School of Medicine</institution>
        <named-content content-type="city">Ehime</named-content>
        <country country="JP">Japan</country>
      </aff>
      <aff id="ana24612-aff-0008">
        <label>
          <sup>8</sup>
        </label>
        <named-content content-type="organisation-division">Department of Neurology</named-content>
        <institution>Tokyo Metropolitan Neurological Hospital</institution>
        <named-content content-type="city">Tokyo</named-content>
        <country country="JP">Japan</country>
      </aff>
      <aff id="ana24612-aff-0009">
        <label>
          <sup>9</sup>
        </label>
        <named-content content-type="organisation-division">Department of Neurology</named-content>
        <institution>Fukushima Medical University</institution>
        <named-content content-type="city">Fukushima</named-content>
        <country country="JP">Japan</country>
      </aff>
      <aff id="ana24612-aff-0010">
        <label>
          <sup>10</sup>
        </label>
        <named-content content-type="organisation-division">Department of Neurology</named-content>
        <institution>Tokyo Medical University</institution>
        <named-content content-type="city">Tokyo</named-content>
        <country country="JP">Japan</country>
      </aff>
      <aff id="ana24612-aff-0011">
        <label>
          <sup>11</sup>
        </label>
        <named-content content-type="organisation-division">Department of Neurology and Stroke Medicine</named-content>
        <institution>Yokohama City University</institution>
        <named-content content-type="city">Yokohama</named-content>
        <country country="JP">Japan</country>
      </aff>
      <aff id="ana24612-aff-0012">
        <label>
          <sup>12</sup>
        </label>
        <named-content content-type="organisation-division">Department of HomeâCare Promotion</named-content>
        <institution>Shinshu University School of Medicine</institution>
        <named-content content-type="city">Matsumoto</named-content>
        <country country="JP">Japan</country>
      </aff>
      <aff id="ana24612-aff-0013">
        <label>
          <sup>13</sup>
        </label>
        <named-content content-type="organisation-division">Department of Neurology</named-content>
        <institution>Showa University School of Medicine</institution>
        <named-content content-type="city">Tokyo</named-content>
        <country country="JP">Japan</country>
      </aff>
      <aff id="ana24612-aff-0014">
        <label>
          <sup>14</sup>
        </label>
        <named-content content-type="organisation-division">Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences</named-content>
        <institution>The University of Tokyo</institution>
        <named-content content-type="city">Chiba</named-content>
        <country country="JP">Japan</country>
      </aff>
      <aff id="ana24612-aff-0015">
        <label>
          <sup>15</sup>
        </label>
        <named-content content-type="organisation-division">Director of North Medical Center</named-content>
        <institution>Kyoto Prefectural University of Medicine</institution>
        <named-content content-type="city">Kyoto</named-content>
        <country country="JP">Japan</country>
      </aff>
      <author-notes>
        <corresp id="correspondenceTo"><label>*</label>Address correspondence to Dr Hiroshi Takashima, Department of Neurology and Geriatrics, Kagoshima University Graduate School of Medical and Dental Sciences, 8â35â1 Sakuragaoka, Kagoshima City, Kagoshima, Japan 890â8520. Eâmail: <email>thiroshi@m3.kufm.kagoshima-u.ac.jp</email></corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>17</day>
        <month>3</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>4</month>
        <year>2016</year>
      </pub-date>
      <volume>79</volume>
      <issue>4</issue>
      <issue-id pub-id-type="doi">10.1002/ana.v79.4</issue-id>
      <fpage>659</fpage>
      <lpage>672</lpage>
      <history>
        <date date-type="received">
          <day>13</day>
          <month>10</month>
          <year>2015</year>
        </date>
        <date date-type="rev-recd">
          <day>16</day>
          <month>1</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>03</day>
          <month>2</month>
          <year>2016</year>
        </date>
      </history>
      <permissions>
        <!--<copyright-statement content-type="issue-copyright"> &#x000a9; 2016 American Neurological Association <copyright-statement>-->
        <copyright-statement content-type="article-copyright">Â© 2016 The Authors. Annals of Neurology published by Wiley Periodicals, Inc. on behalf of American Neurological Association.</copyright-statement>
        <license license-type="creativeCommonsBy-nc">
          <license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">Creative Commons AttributionâNonCommercial</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.</license-p>
        </license>
      </permissions>
      <self-uri content-type="pdf" xlink:type="simple" xlink:href="file:ANA-79-659.pdf"/>
      <abstract>
        <sec id="ana24612-sec-0001">
          <title>Objective</title>
          <p>The objective of this study was to identify new causes of CharcotâMarieâTooth (CMT) disease in patients with autosomalârecessive (AR) CMT.</p>
        </sec>
        <sec id="ana24612-sec-0002">
          <title>Methods</title>
          <p>To efficiently identify novel causative genes for ARâCMT, we analyzed 303 unrelated Japanese patients with CMT using wholeâexome sequencing and extracted recessive variants/genes shared among multiple patients. We performed mutation screening of the newly identified membrane metalloendopeptidase (<italic>MME</italic>) gene in 354 additional patients with CMT. We clinically, genetically, pathologically, and radiologically examined 10 patients with the <italic>MME</italic> mutation.</p>
        </sec>
        <sec id="ana24612-sec-0003">
          <title>Results</title>
          <p>We identified recessive mutations in <italic>MME</italic> in 10 patients. The <italic>MME</italic> gene encodes neprilysin (NEP), which is well known to be one of the most prominent betaâamyloid (AÎ²)âdegrading enzymes. All patients had a similar phenotype consistent with lateâonset axonal neuropathy. They showed muscle weakness, atrophy, and sensory disturbance in the lower extremities. All the <italic>MME</italic> mutations could be lossâofâfunction mutations, and we confirmed a lack/decrease of NEP protein expression in a peripheral nerve. No patients showed symptoms of dementia, and 1 patient showed no excess AÎ² in Pittsburgh compoundâB positron emission tomography imaging.</p>
        </sec>
        <sec id="ana24612-sec-0004">
          <title>Interpretation</title>
          <p>Our results indicate that lossâofâfunction <italic>MME</italic> mutations are the most frequent cause of adultâonset ARâCMT2 in Japan, and we propose that this new disease should be termed ARâCMT2T. A lossâofâfunction <italic>MME</italic> mutation did not cause earlyâonset Alzheimer's disease. Identifying the <italic>MME</italic> mutation responsible for ARâCMT could improve the rate of molecular diagnosis and the understanding of the molecular mechanisms of CMT. Ann Neurol 2016;79:659â672</p>
        </sec>
      </abstract>
      <funding-group>
        <award-group>
          <funding-source>Nervous and Mental Disorders and Research Committee for CharcotâMarieâTooth Disease, Neuropathy, Ataxic Disease and Applying Health and Technology of Ministry of Health, Welfare and Labour, Japan
</funding-source>
        </award-group>
      </funding-group>
      <funding-group>
        <award-group>
          <funding-source>Japan Agency for Medical Research and Development
</funding-source>
        </award-group>
      </funding-group>
      <counts>
        <page-count count="14"/>
      </counts>
      <custom-meta-group>
        <custom-meta>
          <meta-name>source-schema-version-number</meta-name>
          <meta-value>2.0</meta-value>
        </custom-meta>
        <custom-meta>
          <meta-name>component-id</meta-name>
          <meta-value>ana24612</meta-value>
        </custom-meta>
        <custom-meta>
          <meta-name>cover-date</meta-name>
          <meta-value>April 2016</meta-value>
        </custom-meta>
        <custom-meta>
          <meta-name>details-of-publishers-convertor</meta-name>
          <meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:4.9.5 mode:remove_FC converted:19.10.2016</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <p>CharcotâMarieâTooth (CMT) disease is one of the most common inherited peripheral neuropathies (IPNs), and it is clinically and genetically heterogeneous. To date, &gt;100 different genes have been identified as diseaseâcausing genes for CMT and other IPNs. Among them, &gt;20 genes, such as <italic>COX6A1</italic>, <italic>C12orf65</italic>, <italic>EGR2</italic>, <italic>FGD4</italic>, <italic>FIG4</italic>, <italic>GALC</italic>, <italic>GAN</italic>, <italic>GDAP1</italic>, <italic>HINT1</italic>, <italic>HK1</italic>, <italic>LMNA</italic>, <italic>MED25</italic>, <italic>MTMR2</italic>, <italic>MTMR5</italic>, <italic>NDRG1</italic>, <italic>PRX</italic>, <italic>SACS</italic>, <italic>SBF1</italic>, <italic>SBF2</italic>, <italic>SH3TC2</italic>, <italic>SURF1</italic>, and <italic>TRIM2</italic>, have been shown to be involved in autosomalârecessive (AR) CMT (ARâCMT) or other ARâIPNs, and could be categorized into various groups based on their subcellular localization and functions.<xref rid="ana24612-bib-0001" ref-type="ref">1</xref>, <xref rid="ana24612-bib-0002" ref-type="ref">2</xref> Although a genetic diagnosis has been achieved in more than half of all patients with CMT, the molecular diagnosis rate of patients with ARâCMT is extremely low compared with that of patients with autosomalâdominant (AD) CMT, particularly that of CMT1.<xref rid="ana24612-bib-0003" ref-type="ref">3</xref>, <xref rid="ana24612-bib-0004" ref-type="ref">4</xref>, <xref rid="ana24612-bib-0005" ref-type="ref">5</xref> This suggests the presence of causative genes that have yet to be determined and the necessity to study them further, which may result in a better understanding of CMT pathogenesis.</p>
    <p>In this study, we attempted to identify novel ARâCMT diseaseâcausing genes using wholeâexome sequencing (WES) analyses in many patients with CMT with an overlapâbased strategy, which helps identify candidate genes by focusing on variants shared among multiple unrelated patients with the same phenotype.</p>
    <p>We identified mutations in the membrane metalloendopeptidase (<italic>MME</italic>) gene in 10 unrelated patients with adultâonset axonal neuropathy. The <italic>MME</italic> gene encodes neprilysin (NEP), which is termed cluster of differentiation 10 (CD10), and may play a role in degrading a variety of neuropeptides. NEP has been found not only in the central nervous system (CNS), but also the peripheral nervous system (PNS) in mammals.<xref rid="ana24612-bib-0006" ref-type="ref">6</xref>, <xref rid="ana24612-bib-0007" ref-type="ref">7</xref> The role of NEP in PNS is unclear; however, it is well known that NEP is one of the most prominent Î²âamyloid (AÎ²)âdegrading enzymes in the CNS.<xref rid="ana24612-bib-0008" ref-type="ref">8</xref> NEP is recognized to play an important protective role against Alzheimer's disease.<xref rid="ana24612-bib-0009" ref-type="ref">9</xref>, <xref rid="ana24612-bib-0010" ref-type="ref">10</xref>, <xref rid="ana24612-bib-0011" ref-type="ref">11</xref> NEPâdeficient mice showed increased AÎ² accumulation in the brain, which resulted in Alzheimer's diseaseâlike pathology and behavioral abnormalities.<xref rid="ana24612-bib-0012" ref-type="ref">12</xref>, <xref rid="ana24612-bib-0013" ref-type="ref">13</xref> However, it is not yet clear how lossâofâfunction mutations in <italic>MME</italic> affect the human phenotypes.</p>
    <p>Here, we describe the clinical characteristics of patients with CMT with <italic>MME</italic> mutations, including whether or not they show evidence of Alzheimer's disease, and we provide genetic and histopathological data to support the contention that the recessive mutations in <italic>MME</italic> are responsible for CMT.</p>
    <sec id="ana24612-sec-0006">
      <title>Subjects and Methods</title>
      <p>A total of 726 Japanese patients with clinically diagnosed CMT were enrolled in this study. However, demyelinating patients whose <italic>PMP22</italic> duplication or deletion were confirmed using fluorescence in situ hybridization or multiplex ligation probe amplification were not enrolled. The protocol was reviewed and approved by the institutional review board of Kagoshima University (Kagoshima, Japan). All patients and family members provided written informed consent to participate in this study.</p>
      <sec id="ana24612-sec-0007">
        <title>Patient Selection of Original Study for WES</title>
        <p>To identify novel ARâCMT diseaseâcausing genes using WES analyses, we collected DNA samples in a first case series of 372 Japanese patients with clinically diagnosed CMT between April 2007 and April 2012. Subsequently, we excluded 69 patients with pathogenic mutations in the 28 genes known to cause CMT or IPN (Supplementary Table 1), which were detected using the custom MyGeneChip CustomSeq Resequencing Array (Affymetrix, Inc., Santa Clara, CA) following the protocol described previously.<xref rid="ana24612-bib-0014" ref-type="ref">14</xref>, <xref rid="ana24612-bib-0015" ref-type="ref">15</xref>, <xref rid="ana24612-bib-0016" ref-type="ref">16</xref>, <xref rid="ana24612-bib-0017" ref-type="ref">17</xref> We performed WES in the remaining 303 patients and excluded 85 patients with pathogenic mutations in the known CMT genes and in other IPN genes (Supplementary Table 1). We also excluded 55 patients suspected of AD or Xâlinked inheritance pattern on the basis of family history information as well as undetermined inheritance. After these exclusions, we selected 163 unrelated patients with presumed AR inheritance or with sporadic inheritance and no known genetic etiology (Fig <xref rid="ana24612-fig-0001" ref-type="fig">1</xref>).</p>
        <fig fig-type="Figure" xml:lang="en" id="ana24612-fig-0001" orientation="portrait" position="float">
          <label>Figure 1</label>
          <caption>
            <p>Flow chart for genetic tests, selection of patients, and exomeâbased shared variants detection (ESVD) system among the first case series of 372 CharcotâMarieâTooth (CMT) patients, we selected 163 patients with presumed autosomalârecessive or sporadic CMT and no known genetic etiology. Using the ESVD system, we automatically performed variant filtering under the conditions (1) to (6). Subsequently, we identified 5 patients with a mutation in the <italic>MME</italic> gene by the shared variants/genes pickup system. AD = autosomalâdominant; AR = autosomalârecessive; SNV = singleânucleotide variation; MAF = minor allele frequency.</p>
          </caption>
          <graphic id="nlm-graphic-1" xlink:href="ANA-79-659-g001"/>
        </fig>
      </sec>
      <sec id="ana24612-sec-0008">
        <title>Patient Selection of Additional Study</title>
        <p>To investigate whether <italic>MME</italic> mutations cause CMT and to investigate the frequency of patients with <italic>MME</italic> mutations, we further performed targeted resequencing using nextâgeneration sequencing (NGS) in a 137 second case series between May 2012 and June 2014 and a 217 third case series of unrelated Japanese patients with CMT between July 2014 and March 2015 (Fig <xref rid="ana24612-fig-0002" ref-type="fig">2</xref>).</p>
        <fig fig-type="Figure" xml:lang="en" id="ana24612-fig-0002" orientation="portrait" position="float">
          <label>Figure 2</label>
          <caption>
            <p>Flow chart for genetic tests in the additional patients. During the second and third case series, we identified 1 and 4 patients with mutations in the <italic>MME</italic> gene.</p>
          </caption>
          <graphic id="nlm-graphic-3" xlink:href="ANA-79-659-g002"/>
        </fig>
      </sec>
      <sec id="ana24612-sec-0009">
        <title>Extraction of Genomic DNA</title>
        <p>Genomic DNA of the patients and family members was extracted from peripheral blood using QIAGEN's Puregene Core Kit C (QIAGEN, Valencia, CA) or from saliva using the Oragene DNA selfâcollection kit (DNA Genotech, Ottawa, Ontario, Canada), according to the manufacturer's protocol.</p>
      </sec>
      <sec id="ana24612-sec-0010">
        <title>WES</title>
        <p>Three micrograms of genomic DNA were processed using a SureSelect v4+UTRs or v5+UTRs kit according to the manufacturer's instructions. Captured DNA was sequenced using a HiSeq 2000 (Illumina, San Diego, CA). Sequences were aligned to the human reference genome (NCBI37/hg19) using the BurrowsâWheeler Aligner.<xref rid="ana24612-bib-0018" ref-type="ref">18</xref> Variant calling was performed using SAMtools.<xref rid="ana24612-bib-0019" ref-type="ref">19</xref> Variants were annotated using inâhouse scripts, which provided the variants list. Previously known variants were annotated from the 1000 Genomes Project and dbSNP137.</p>
      </sec>
      <sec id="ana24612-sec-0011">
        <title>Development of the ExomeâBased Shared Variants Detection System</title>
        <p>To extract candidate genes or variants from the WES data, Maze Inc. (Tokyo, Japan) developed userâfriendly analysis software, called the exomeâbased shared variants detection (ESVD) system, under our supervision. This system consists of two parts: a âvariantâfiltering systemâ and a âshared variants/genes pickup system.â The variantâfiltering system provides users with many options for filtering the raw variant data. The conditions for filtering variants include mutation type, genotype, quality, read depth, minor allele frequency (MAF), and presence in public databases; dbSNP137, 1000 Genomes project database (<ext-link ext-link-type="uri" xlink:href="http://browser.1000genomes.org">http://browser.1000genomes.org</ext-link>), and The Human Genetic Variation Database (HGVD) comprised of exome sequencing of 1,208 Japanese individuals (<ext-link ext-link-type="uri" xlink:href="http://www.genome.med.kyoto-u.ac.jp/SnpDB/">http://www.genome.med.kyotoâu.ac.jp/SnpDB/</ext-link>). Moreover, the shared variants/genes pickup system allowed us to detect the variants and genes shared among cases with similar phenotypes, and the number can be custom defined. In this study, using the ESVD system, we automatically performed variant filtering under the following conditions: (1) mutation type (singleânucleotide variation [SNV]; not including insertion and deletion); (2) mutation classification (nonsynonymous, nonsense, and splicing site variants); (3) genotype (homozygous); (4) Phredâscaled quality score/mapping quality (both &gt;20); (5) read depth (&gt; 10); and (6) existence in the public database (none or MAF &lt;1%). Subsequently, we manually selected the variants on an autosome. Eventually, after filtering, the variants that were shared by three or more cases were extracted (Fig <xref rid="ana24612-fig-0001" ref-type="fig">1</xref>). We also manually extracted presumed compound heterozygous variants of the <italic>MME</italic> gene from the WES data set of the 163 patients.</p>
      </sec>
      <sec id="ana24612-sec-0012">
        <title>Mutation Screening of the <italic>MME</italic> Gene in the Additional Patients</title>
        <p>For the second series, we performed mutation screening of 60 known or candidate CMTârelated genes using the Illumina Miseq platform (Illumina Inc., San Diego, CA, USA) following the protocol described previously by Maeda et al.<xref rid="ana24612-bib-0020" ref-type="ref">20</xref> Subsequently, we performed mutation screening of other known CMT and IPN genes, including the <italic>MME</italic> gene, using WES (Fig <xref rid="ana24612-fig-0002" ref-type="fig">2</xref>). For the third series, we performed targeted resequencing of 72 known or candidate CMTârelated genes, including the <italic>MME</italic> gene, using a custom Ion AmpliSeq<sup>M</sup> panel (Life Technologies, Carlsbad, CA) (Fig <xref rid="ana24612-fig-0002" ref-type="fig">2</xref> and Supplementary Table 1). Briefly, a custom panel targeting 72 genes was designed using the Ion AmpliSeq Designer tool (<ext-link ext-link-type="uri" xlink:href="http://www.ampliseq.com">http://www.ampliseq.com</ext-link>). Library and template preparation was performed according to manufacturer's instructions. Sequencing was performed on the Ion Proton (Life Technologies) using the Ion PI Chip kit v2 BC. Sequence data were aligned and mapped to the reference sequence, and variants were called using the Torrent variant caller. Variants were transferred to the CLC Genomics Workbench 6 software program (CLC bio, Aarhus, Denmark) for annotation and filtering.</p>
      </sec>
      <sec id="ana24612-sec-0013">
        <title>Mutation Confirmation and Segregation Analysis</title>
        <p>Using Sanger sequencing, we reconfirmed the pathogenic mutations revealed by microarray or NGS. Furthermore, segregation studies were performed in the available family members whenever possible. In order to rule out the possibility that the prioritized variants in the <italic>MME</italic> gene may be Japaneseâspecific polymorphisms, we confirmed whether the variants that existed in the inâhouse database comprised of the WES data from 800 Japanese healthy control subjects and 3,742 disease control subjects excluding patients with CMT.</p>
      </sec>
      <sec id="ana24612-sec-0014">
        <title>In Silico Analysis</title>
        <p>To determine whether variants in the <italic>MME</italic> gene are damaging or deleterious, we obtained the predicted functional scores of nonsynonymous variants or deletions with three prediction algorithms, including PolyPhen2,<xref rid="ana24612-bib-0021" ref-type="ref">21</xref> SIFT (Sorts Intolerant From Tolerant amino acid substitutions),<xref rid="ana24612-bib-0022" ref-type="ref">22</xref> and PROVEAN (Protein Variation Effect Analyzer).<xref rid="ana24612-bib-0023" ref-type="ref">23</xref>
</p>
      </sec>
      <sec id="ana24612-sec-0015">
        <title>RNA Extraction and ReverseâTranscription Polymerase Chain Reaction</title>
        <p>To study the messenger RNA (mRNA) expression of the <italic>MME</italic> gene, we performed reverseâtranscription polymerase chain reaction (RTâPCR) in individuals from some families with <italic>MME</italic> mutations. Whole blood was collected into PAXgene Blood RNA Tubes (Qiagen), and total RNA was prepared from blood using the PAXgene Blood RNA Kit (Qiagen) in order to generate a complementary DNA (cDNA) pool by RTâPCR using the HighâCapacity cDNA Reverse Transcription Kit (Applied Biosystems, Carlsbad, CA), according to the manufacturer's instructions. PCR primers for the Î²âactin housekeeping gene were used as the internal control. <italic>MME</italic> cDNAs were amplified using the following primer pairs: (1) forward primer located in exon 6: 5â²âTGATAGCAGAGGTGGAGAACCâ3â² and reverse primer in exon 9: 5â²âCATCGATGGGCAATCTTTCTâ3â²; (II) forward primer in exon 4: 5â²âAATGTCATTCCCGAGACCAGâ3â², reverse primer in exon 7: 5â²âTCATCAGTGCCAACAAACAAâ3â². The expected sizes of the RTâPCR products were 350bp (base pairs) and 344bp for primer pairs 1 and 2, respectively. PCR products were subjected to agarose gel electrophoresis and sequenced using the Sanger method.</p>
      </sec>
      <sec id="ana24612-sec-0016">
        <title>Haplotype Analyses</title>
        <p>To determine whether recurring <italic>MME</italic> mutations (c.654+1G&gt;A) occurred because of independent mutational events or common ancestry, we performed a haplotype analysis using five microsatellite markers (D3S1595, D3S1280, D3S3509, D3S1275, and D3S3692) and seven singleânucleotide polymorphisms (SNPs; rs1803155, rs12493885, rs12497267, rs9438, rs358733, rs11918974, and rs3816527) flanking the <italic>MME</italic> gene by an automated fluorescent method on an ABI 3130xL or 3500xL genetic analyzer (Applied Biosystems).</p>
      </sec>
      <sec id="ana24612-sec-0017">
        <title>Cognitive Assessment and Neuroimaging</title>
        <p>In some patients, we performed brain magnetic resonance imaging (MRI) or computed tomography (CT), and a neuropsychological examination including the MiniâMental State Examination (MMSE; 0â30 scale, normal &gt;24)<xref rid="ana24612-bib-0024" ref-type="ref">24</xref> and the Alzheimer's Disease Assessment ScaleâCognitive Behavior Section (ADASâcog; 0â70 scale, normal &lt;10).<xref rid="ana24612-bib-0025" ref-type="ref">25</xref> We also evaluated patient 1 (P1) with amyloid positron emission tomography (PET) imaging with <sup>11</sup>CâPIB (Pittsburgh compoundâB). PET data were acquired on a Discovery PET/CT 710 (GE Healthcare, Tokyo, Japan) after the injection of <sup>11</sup>CâPiB (470 MBq). <sup>11</sup>CâPiB images were derived from dynamic summations of standard uptake values (SUVs) over 60âminutes and were normalized with the cerebellum as a reference region (SUVR).</p>
      </sec>
      <sec id="ana24612-sec-0018">
        <title>Histopathological Examinations</title>
        <p>Sural nerve biopsies obtained from P1 and P4 were analyzed for morphometric changes using light microscopes. Semithin sections from Epon embedded tissues were stained with Toluidine blue. An immunohistochemical assay was performed using an antiâNEP/CD10 antibody (ab951; Abcam, Tokyo, Japan) in tissue from human tonsils and peripheral nerves, and the findings were compared to a disease control patient (female, 39 years old, polymyositis).</p>
      </sec>
      <sec id="ana24612-sec-0019">
        <title>Western blotting</title>
        <p>Western blotting was performed using sodium dodecyl sulfate/polyacrylamide gel electrophoresis. Briefly, 20âÎ¼g homogenates of sural nerve were resuspended in a reduced sample buffer, electrophoresed on a 10% Tris gel with Tris running buffer, blotted to a polyvinylidene difluoride membrane, and sequentially probed with polyclonal rabbit antihuman CD10 antibody (Abcam). The membrane was subsequently incubated with a horseradish peroxidaseâlabeled polymerâconjugated antimouse antibody reagent (EnVision+ reagent; Dako, Tokyo, Japan). 3â3â²âdiaminobenzidine was used for chromogenic visualization.</p>
      </sec>
    </sec>
    <sec id="ana24612-sec-0020">
      <title>Results</title>
      <sec id="ana24612-sec-0021">
        <title>Identification of <italic>MME</italic> Mutations</title>
        <p>Figure <xref rid="ana24612-fig-0001" ref-type="fig">1</xref> shows a flow chart for the selection of patients, genetic tests, and the filtering process for homozygous variants using the ESVD system. We extracted three kinds of homozygous mutations in the <italic>MME</italic> gene in 5 patients in the first case series of patients with CMT with no pathogenic mutations in known CMT or IPN genes. In P1 to P3, we identified the same homozygous mutation in the splice donor site [c.654+1G&gt;A] in intron 7 of <italic>MME</italic>. A novel homozygous missense mutation [c.1861T&gt;C, p.Cys621Arg] and a nonsense mutation [c.661C&gt;T, p.Gln221X] were found in P4 and P5, respectively. On the other hand, we could not extract presumed compound heterozygous variants or other homozygous variants in <italic>MME</italic> from the WES data of 163 AR/sporadic cases in first case series, although we identified a novel heterozygous nonsense variant of unknown significant (c.264C&gt;A, p.Cys88X) and a rare SNV (c.1489T&gt;C, p.Typ497His). In the second and third case series of patients with CMT with no pathogenic mutations in known CMT or IPN genes, five additional recessive mutations in the <italic>MME</italic> gene were identified (Fig <xref rid="ana24612-fig-0002" ref-type="fig">2</xref>): [c.1231_1233delTGT, p.Cys411del], [c.439+2T&gt;A], [c.439+2T&gt;A and c.655â2A&gt;G (compound heterozygous mutation)], [c.1817G&gt;A, p.Trp606X], and [c.655â2A&gt;G] mutations in P6 to P10, respectively (Table <xref rid="ana24612-tbl-0001" ref-type="table-wrap">1</xref>). Segregation analysis from the families of P1, P4, P6, P7, P8, and P10 revealed that the <italic>MME</italic> mutations were segregated with the disease in each family (Fig <xref rid="ana24612-fig-0003" ref-type="fig">3</xref>). Glutamine 221, cysteine 411, tryptophan 606, cysteine 621, and canonical GTâAG nucleotides of the splice donor and acceptor junctions in the <italic>MME</italic> gene were highly conserved among species (Fig <xref rid="ana24612-fig-0004" ref-type="fig">4</xref>AâC). Notably, the p.Cys621Arg mutation was classified as âpathogenicâ or âdeleteriousâ using in silico analysis (Polyphen2 score = 1.00, SIFT score = 0.00, and PROVEAN score = â11.2 [cutoff = â2.5]), and the p.Cys411del mutation was also predicted as deleterious in the PROVEAN software (PROVEAN score = â17.4 [cutoff = â2.5]). MAF of all the validated mutations in public databases, including Exome Sequencing Project (ESP) and Exome Aggregation Consortium (ExAC), and inâhouse database was â¤0.002 (Supplementary Table 2).</p>
        <table-wrap id="ana24612-tbl-0001" xml:lang="en" orientation="portrait" position="float">
          <label>Table 1</label>
          <caption>
            <p>Genetic, Clinical, and Laboratory Findings</p>
          </caption>
          <table frame="hsides" rules="groups">
            <col style="border-right:solid 1px #000000border-bottom:solid 1px #000000" span="1"/>
            <col style="border-right:solid 1px #000000border-bottom:solid 1px #000000" span="1"/>
            <col style="border-right:solid 1px #000000border-bottom:solid 1px #000000" span="1"/>
            <col style="border-right:solid 1px #000000border-bottom:solid 1px #000000" span="1"/>
            <col style="border-right:solid 1px #000000border-bottom:solid 1px #000000" span="1"/>
            <col style="border-right:solid 1px #000000border-bottom:solid 1px #000000" span="1"/>
            <col style="border-right:solid 1px #000000border-bottom:solid 1px #000000" span="1"/>
            <col style="border-right:solid 1px #000000border-bottom:solid 1px #000000" span="1"/>
            <col style="border-right:solid 1px #000000border-bottom:solid 1px #000000" span="1"/>
            <col style="border-right:solid 1px #000000border-bottom:solid 1px #000000" span="1"/>
            <col style="border-right:solid 1px #000000border-bottom:solid 1px #000000" span="1"/>
            <thead valign="bottom">
              <tr valign="bottom" style="border-bottom:solid 1px #000000">
                <th align="center" valign="bottom" rowspan="1" colspan="1">Patient No.</th>
                <th align="center" valign="bottom" rowspan="1" colspan="1">P1</th>
                <th align="center" valign="bottom" rowspan="1" colspan="1">P2</th>
                <th align="center" valign="bottom" rowspan="1" colspan="1">P3</th>
                <th align="center" valign="bottom" rowspan="1" colspan="1">P4</th>
                <th align="center" valign="bottom" rowspan="1" colspan="1">P5</th>
                <th align="center" valign="bottom" rowspan="1" colspan="1">P6</th>
                <th align="center" valign="bottom" rowspan="1" colspan="1">P7</th>
                <th align="center" valign="bottom" rowspan="1" colspan="1">P8</th>
                <th align="center" valign="bottom" rowspan="1" colspan="1">P9</th>
                <th align="center" valign="bottom" rowspan="1" colspan="1">P10</th>
              </tr>
            </thead>
            <tbody valign="top">
              <tr valign="bottom">
                <td align="left" valign="bottom" rowspan="1" colspan="1">Mutation</td>
                <td align="center" valign="bottom" rowspan="1" colspan="1">c.654+1G&gt;A (p.Gly179fs)</td>
                <td align="center" valign="bottom" rowspan="1" colspan="1">
c.654+1G&gt;A<break/>
(p.Gly179fs)</td>
                <td align="center" valign="bottom" rowspan="1" colspan="1">
c.654+1G&gt;A<break/>
(p.Gly179fs)</td>
                <td align="center" valign="bottom" rowspan="1" colspan="1">
c.1861T&gt;C<break/>
(p.Cys621Arg)</td>
                <td align="center" valign="bottom" rowspan="1" colspan="1">
c.661C&gt;T<break/>
(p.Gln221X)</td>
                <td align="center" valign="bottom" rowspan="1" colspan="1">
c.1231_1233delTGT<break/>
(p.Cys411del)</td>
                <td align="center" valign="bottom" rowspan="1" colspan="1">
c.439+2T&gt;A<break/>
(p.exon5del)</td>
                <td align="center" valign="bottom" rowspan="1" colspan="1">
c.439+2T&gt;A<break/>
(p.exon5del)<break/>
c.655â2A&gt;G<break/>
(p.exon8del)</td>
                <td align="center" valign="bottom" rowspan="1" colspan="1">
c.1817G&gt;A<break/>
(p.Trp606X)</td>
                <td align="center" valign="bottom" rowspan="1" colspan="1">
c.655â2A&gt;G<break/>
(p.exon8del)</td>
              </tr>
              <tr valign="top">
                <td align="left" valign="top" rowspan="1" colspan="1">Genotype</td>
                <td align="center" valign="top" rowspan="1" colspan="1">Hmz</td>
                <td align="center" valign="top" rowspan="1" colspan="1">Hmz</td>
                <td align="center" valign="top" rowspan="1" colspan="1">Hmz</td>
                <td align="center" valign="top" rowspan="1" colspan="1">Hmz</td>
                <td align="center" valign="top" rowspan="1" colspan="1">Hmz</td>
                <td align="center" valign="top" rowspan="1" colspan="1">Hmz</td>
                <td align="center" valign="top" rowspan="1" colspan="1">Hmz</td>
                <td align="center" valign="top" rowspan="1" colspan="1">CH</td>
                <td align="center" valign="top" rowspan="1" colspan="1">Hmz</td>
                <td align="center" valign="top" rowspan="1" colspan="1">Hmz</td>
              </tr>
              <tr valign="top">
                <td align="left" valign="top" rowspan="1" colspan="1">Classification</td>
                <td align="center" valign="top" rowspan="1" colspan="1">Splice</td>
                <td align="center" valign="top" rowspan="1" colspan="1">Splice</td>
                <td align="center" valign="top" rowspan="1" colspan="1">Splice</td>
                <td align="center" valign="top" rowspan="1" colspan="1">Missense</td>
                <td align="center" valign="top" rowspan="1" colspan="1">Nonsense</td>
                <td align="center" valign="top" rowspan="1" colspan="1">Deletion</td>
                <td align="center" valign="top" rowspan="1" colspan="1">Splice</td>
                <td align="center" valign="top" rowspan="1" colspan="1">Splice</td>
                <td align="center" valign="top" rowspan="1" colspan="1">Nonsense</td>
                <td align="center" valign="top" rowspan="1" colspan="1">Splice</td>
              </tr>
              <tr valign="top">
                <td align="left" valign="top" rowspan="1" colspan="1">Sex/age, yr</td>
                <td align="center" valign="top" rowspan="1" colspan="1">M/67</td>
                <td align="center" valign="top" rowspan="1" colspan="1">M/49</td>
                <td align="center" valign="top" rowspan="1" colspan="1">M/59</td>
                <td align="center" valign="top" rowspan="1" colspan="1">M/66</td>
                <td align="center" valign="top" rowspan="1" colspan="1">M/58</td>
                <td align="center" valign="top" rowspan="1" colspan="1">F/65</td>
                <td align="center" valign="top" rowspan="1" colspan="1">M/73</td>
                <td align="center" valign="top" rowspan="1" colspan="1">M/51</td>
                <td align="center" valign="top" rowspan="1" colspan="1">M/54</td>
                <td align="center" valign="top" rowspan="1" colspan="1">F/47</td>
              </tr>
              <tr valign="top">
                <td align="left" valign="top" rowspan="1" colspan="1">Onset age, yr</td>
                <td align="center" valign="top" rowspan="1" colspan="1">54</td>
                <td align="center" valign="top" rowspan="1" colspan="1">36</td>
                <td align="center" valign="top" rowspan="1" colspan="1">50</td>
                <td align="center" valign="top" rowspan="1" colspan="1">56</td>
                <td align="center" valign="top" rowspan="1" colspan="1">48</td>
                <td align="center" valign="top" rowspan="1" colspan="1">54</td>
                <td align="center" valign="top" rowspan="1" colspan="1">50</td>
                <td align="center" valign="top" rowspan="1" colspan="1">47</td>
                <td align="center" valign="top" rowspan="1" colspan="1">40</td>
                <td align="center" valign="top" rowspan="1" colspan="1">37</td>
              </tr>
              <tr valign="top">
                <td align="left" valign="top" rowspan="1" colspan="1">Inheritance pattern</td>
                <td align="center" valign="top" rowspan="1" colspan="1">AR</td>
                <td align="center" valign="top" rowspan="1" colspan="1">AR</td>
                <td align="center" valign="top" rowspan="1" colspan="1">AR</td>
                <td align="center" valign="top" rowspan="1" colspan="1">AR</td>
                <td align="center" valign="top" rowspan="1" colspan="1">AR</td>
                <td align="center" valign="top" rowspan="1" colspan="1">AR</td>
                <td align="center" valign="top" rowspan="1" colspan="1">AR</td>
                <td align="center" valign="top" rowspan="1" colspan="1">AR/sporadic</td>
                <td align="center" valign="top" rowspan="1" colspan="1">AR</td>
                <td align="center" valign="top" rowspan="1" colspan="1">AR</td>
              </tr>
              <tr valign="top">
                <td align="left" valign="top" rowspan="1" colspan="1">Consanguinity</td>
                <td align="center" valign="top" rowspan="1" colspan="1">+</td>
                <td align="center" valign="top" rowspan="1" colspan="1">+</td>
                <td align="center" valign="top" rowspan="1" colspan="1">â</td>
                <td align="center" valign="top" rowspan="1" colspan="1">+</td>
                <td align="center" valign="top" rowspan="1" colspan="1">+</td>
                <td align="center" valign="top" rowspan="1" colspan="1">â</td>
                <td align="center" valign="top" rowspan="1" colspan="1">+</td>
                <td align="center" valign="top" rowspan="1" colspan="1">â</td>
                <td align="center" valign="top" rowspan="1" colspan="1">â</td>
                <td align="center" valign="top" rowspan="1" colspan="1">+</td>
              </tr>
              <tr valign="top">
                <td align="left" valign="top" rowspan="1" colspan="1">Initial symptom<xref ref-type="fn" rid="ana24612-note-0001">a</xref>
</td>
                <td align="center" valign="top" rowspan="1" colspan="1">Motor</td>
                <td align="center" valign="top" rowspan="1" colspan="1">Motor</td>
                <td align="center" valign="top" rowspan="1" colspan="1">Motor</td>
                <td align="center" valign="top" rowspan="1" colspan="1">Motor</td>
                <td align="center" valign="top" rowspan="1" colspan="1">Motor</td>
                <td align="center" valign="top" rowspan="1" colspan="1">Motor</td>
                <td align="center" valign="top" rowspan="1" colspan="1">Motor</td>
                <td align="center" valign="top" rowspan="1" colspan="1">Sensory</td>
                <td align="center" valign="top" rowspan="1" colspan="1">Motor</td>
                <td align="center" valign="top" rowspan="1" colspan="1">Sensory</td>
              </tr>
              <tr valign="top">
                <td align="left" valign="top" rowspan="1" colspan="1">MMT<xref ref-type="fn" rid="ana24612-note-0002">b</xref>
</td>
                <td align="center" valign="top" rowspan="1" colspan="1">1</td>
                <td align="center" valign="top" rowspan="1" colspan="1">2</td>
                <td align="center" valign="top" rowspan="1" colspan="1">1</td>
                <td align="center" valign="top" rowspan="1" colspan="1">3</td>
                <td align="center" valign="top" rowspan="1" colspan="1">3</td>
                <td align="center" valign="top" rowspan="1" colspan="1">2</td>
                <td align="center" valign="top" rowspan="1" colspan="1">4</td>
                <td align="center" valign="top" rowspan="1" colspan="1">4</td>
                <td align="center" valign="top" rowspan="1" colspan="1">1</td>
                <td align="center" valign="top" rowspan="1" colspan="1">3</td>
              </tr>
              <tr valign="top">
                <td align="left" valign="top" rowspan="1" colspan="1">Sensory disturbance</td>
                <td align="center" valign="top" rowspan="1" colspan="1">+</td>
                <td align="center" valign="top" rowspan="1" colspan="1">+</td>
                <td align="center" valign="top" rowspan="1" colspan="1">+</td>
                <td align="center" valign="top" rowspan="1" colspan="1">+</td>
                <td align="center" valign="top" rowspan="1" colspan="1">+</td>
                <td align="center" valign="top" rowspan="1" colspan="1">â</td>
                <td align="center" valign="top" rowspan="1" colspan="1">+</td>
                <td align="center" valign="top" rowspan="1" colspan="1">+</td>
                <td align="center" valign="top" rowspan="1" colspan="1">+</td>
                <td align="center" valign="top" rowspan="1" colspan="1">+</td>
              </tr>
              <tr valign="top">
                <td align="left" valign="top" rowspan="1" colspan="1">Decreased DTRs</td>
                <td align="center" valign="top" rowspan="1" colspan="1">+</td>
                <td align="center" valign="top" rowspan="1" colspan="1">+</td>
                <td align="center" valign="top" rowspan="1" colspan="1">+</td>
                <td align="center" valign="top" rowspan="1" colspan="1">+</td>
                <td align="center" valign="top" rowspan="1" colspan="1">+</td>
                <td align="center" valign="top" rowspan="1" colspan="1">+</td>
                <td align="center" valign="top" rowspan="1" colspan="1">+</td>
                <td align="center" valign="top" rowspan="1" colspan="1">+</td>
                <td align="center" valign="top" rowspan="1" colspan="1">+</td>
                <td align="center" valign="top" rowspan="1" colspan="1">+</td>
              </tr>
              <tr valign="top">
                <td align="left" valign="top" rowspan="1" colspan="1">Dementia</td>
                <td align="center" valign="top" rowspan="1" colspan="1">â</td>
                <td align="center" valign="top" rowspan="1" colspan="1">â</td>
                <td align="center" valign="top" rowspan="1" colspan="1">NA</td>
                <td align="center" valign="top" rowspan="1" colspan="1">â</td>
                <td align="center" valign="top" rowspan="1" colspan="1">â</td>
                <td align="center" valign="top" rowspan="1" colspan="1">â</td>
                <td align="center" valign="top" rowspan="1" colspan="1">â</td>
                <td align="center" valign="top" rowspan="1" colspan="1">â</td>
                <td align="center" valign="top" rowspan="1" colspan="1">â</td>
                <td align="center" valign="top" rowspan="1" colspan="1">â</td>
              </tr>
              <tr valign="top">
                <td align="left" valign="top" rowspan="1" colspan="1">MMSE</td>
                <td align="center" valign="top" rowspan="1" colspan="1">29</td>
                <td align="center" valign="top" rowspan="1" colspan="1">30</td>
                <td align="center" valign="top" rowspan="1" colspan="1">NA</td>
                <td align="center" valign="top" rowspan="1" colspan="1">29</td>
                <td align="center" valign="top" rowspan="1" colspan="1">28</td>
                <td align="center" valign="top" rowspan="1" colspan="1">29</td>
                <td align="center" valign="top" rowspan="1" colspan="1">26</td>
                <td align="center" valign="top" rowspan="1" colspan="1">30</td>
                <td align="center" valign="top" rowspan="1" colspan="1">28</td>
                <td align="center" valign="top" rowspan="1" colspan="1">30</td>
              </tr>
              <tr valign="top">
                <td align="left" valign="top" rowspan="1" colspan="1">Brain atrophy<xref ref-type="fn" rid="ana24612-note-0003">c</xref>
</td>
                <td align="center" valign="top" rowspan="1" colspan="1">â</td>
                <td align="center" valign="top" rowspan="1" colspan="1">NA</td>
                <td align="center" valign="top" rowspan="1" colspan="1">NA</td>
                <td align="center" valign="top" rowspan="1" colspan="1">â</td>
                <td align="center" valign="top" rowspan="1" colspan="1">â</td>
                <td align="center" valign="top" rowspan="1" colspan="1">NA</td>
                <td align="center" valign="top" rowspan="1" colspan="1">NA</td>
                <td align="center" valign="top" rowspan="1" colspan="1">â</td>
                <td align="center" valign="top" rowspan="1" colspan="1">NA</td>
                <td align="center" valign="top" rowspan="1" colspan="1">â</td>
              </tr>
              <tr valign="top">
                <td align="left" valign="top" rowspan="1" colspan="1">Type</td>
                <td align="center" valign="top" rowspan="1" colspan="1">Ax</td>
                <td align="center" valign="top" rowspan="1" colspan="1">Ax</td>
                <td align="center" valign="top" rowspan="1" colspan="1">Ax</td>
                <td align="center" valign="top" rowspan="1" colspan="1">Ax</td>
                <td align="center" valign="top" rowspan="1" colspan="1">De/Ax</td>
                <td align="center" valign="top" rowspan="1" colspan="1">Ax</td>
                <td align="center" valign="top" rowspan="1" colspan="1">Ax</td>
                <td align="center" valign="top" rowspan="1" colspan="1">Ax</td>
                <td align="center" valign="top" rowspan="1" colspan="1">Ax</td>
                <td align="center" valign="top" rowspan="1" colspan="1">Ax</td>
              </tr>
              <tr valign="top">
                <td align="left" valign="top" rowspan="1" colspan="1">NCS<xref ref-type="fn" rid="ana24612-note-0004">d</xref>âââââDL</td>
                <td align="char" char="." valign="top" rowspan="1" colspan="1">3.2</td>
                <td align="center" valign="top" rowspan="1" colspan="1">4.3</td>
                <td align="center" valign="top" rowspan="1" colspan="1">3.6</td>
                <td align="center" valign="top" rowspan="1" colspan="1">6.3</td>
                <td align="center" valign="top" rowspan="1" colspan="1">4.3</td>
                <td align="center" valign="top" rowspan="1" colspan="1">3.3</td>
                <td align="center" valign="top" rowspan="1" colspan="1">4.5</td>
                <td align="center" valign="top" rowspan="1" colspan="1">4.6</td>
                <td align="center" valign="top" rowspan="1" colspan="1">3.6</td>
                <td align="center" valign="top" rowspan="1" colspan="1">3.5</td>
              </tr>
              <tr valign="top">
                <td align="left" valign="top" rowspan="1" colspan="1">âââââââdCMAP</td>
                <td align="char" char="." valign="top" rowspan="1" colspan="1">6.4</td>
                <td align="center" valign="top" rowspan="1" colspan="1">4.5</td>
                <td align="center" valign="top" rowspan="1" colspan="1">10</td>
                <td align="center" valign="top" rowspan="1" colspan="1">3.2</td>
                <td align="center" valign="top" rowspan="1" colspan="1">4.5</td>
                <td align="center" valign="top" rowspan="1" colspan="1">6.9</td>
                <td align="center" valign="top" rowspan="1" colspan="1">8.2</td>
                <td align="center" valign="top" rowspan="1" colspan="1">1.7</td>
                <td align="center" valign="top" rowspan="1" colspan="1">4.7</td>
                <td align="center" valign="top" rowspan="1" colspan="1">7.3</td>
              </tr>
              <tr valign="top">
                <td align="center" valign="top" rowspan="1" colspan="1">âââââââMCV</td>
                <td align="char" char="." valign="top" rowspan="1" colspan="1">47.5</td>
                <td align="center" valign="top" rowspan="1" colspan="1">42.8</td>
                <td align="center" valign="top" rowspan="1" colspan="1">53</td>
                <td align="center" valign="top" rowspan="1" colspan="1">45.5</td>
                <td align="center" valign="top" rowspan="1" colspan="1">37.4</td>
                <td align="center" valign="top" rowspan="1" colspan="1">45.1</td>
                <td align="center" valign="top" rowspan="1" colspan="1">41.3</td>
                <td align="center" valign="top" rowspan="1" colspan="1">39.2</td>
                <td align="center" valign="top" rowspan="1" colspan="1">45</td>
                <td align="center" valign="top" rowspan="1" colspan="1">42</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="ana24612-note-0001">
              <label>a</label>
              <p>âMotorâ indicates distal lower limbs weakness/atrophy or gait disturbance, and âSensoryâ indicates decreased superficial sensation or dysesthesia in lower limbs.</p>
            </fn>
            <fn id="ana24612-note-0002">
              <label>b</label>
              <p>Scores indicating manual muscle testing (MMT) grade in the distal lower limbs.</p>
            </fn>
            <fn id="ana24612-note-0003">
              <label>c</label>
              <p>Brain atrophy is evaluated by CT or MRI.</p>
            </fn>
            <fn id="ana24612-note-0004">
              <label>d</label>
              <p>Nerve conduction study of Median nerve.</p>
            </fn>
            <fn id="ana24612-note-0005">
              <p>Ax = axonal; CH = compound heterozygous; CT computed tomography; dCMAP = distal compound muscle action potential (mV); De = demyelinating; DL = distal latency (ms); DTRs = deep tendon reflexes; Htz = heterozygous; Hmz = homozygous; MCV = motor conduction velocity (m/s); MMSE = MiniâMental State Examination; MRI = magnetic resonance imaging; NA = not available (not scored or not examined); NCS = nerve conduction study.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <fig fig-type="Figure" xml:lang="en" id="ana24612-fig-0003" orientation="portrait" position="float">
          <label>Figure 3</label>
          <caption>
            <p>Pedigrees and segregation analysis of <italic>MME</italic> mutations in 10 families. P1, P2, P4, P5, P7, and P10 have consanguineous parents. P3, P6, and P9 have unaffected parents with affected siblings, and P8 was sporadic. Autosomalârecessive inheritance is presumed in all pedigrees. A DNA sample was available from individuals marked with an asterisk. Affected members have a homozygous or compound heterozygous mutation, whereas unaffected members were heterozygous or wildâtype carriers. Squares represent males and circles represent females. Filled symbols represent those affected with a similar phenotype. Oblique lines represent deceased family members. Black arrows indicate the proband (P1âP10). +/+ = homozygous for mutation; +/â = heterozygous; â/â = homozygous for wild type.</p>
          </caption>
          <graphic id="nlm-graphic-5" xlink:href="ANA-79-659-g003"/>
        </fig>
        <fig fig-type="Figure" xml:lang="en" id="ana24612-fig-0004" orientation="portrait" position="float">
          <label>Figure 4</label>
          <caption>
            <p>Localization and conservation of <italic>MME</italic> mutations, haplotype analysis, and RNA analysis. (A and B) Schematic representation of the <italic>MME</italic> gene and neprilysin. Red arrows indicate the location of mutations in the extracellular domain. N = Nâglycosylation sites; TM = transmembrane domain. (C) Conservation analysis. Glutamine 221, cysteine 411, tryptophan 606, cysteine 621, and canonical GTâAG nucleotides (c.439+2t, c.654+1g, c.655â2a) of the splice donor and acceptor junctions in the <italic>MME</italic> gene were highly conserved among species. (D) Agarose gel electrophoresis of cDNA fragments obtained from RTâPCR of P1, his family member (IVâ4, Vâ2, IVâ9, and Vâ5), P3 with the c.654+1G&gt;A mutation, P5 with c.661C&gt;T mutation, and a normal control (NC). The P1, IVâ4 (affected), IVâ9 (affected), and P3 lanes showed a 231âbp band, which is smaller than the 350âbp band in the NC lane. The Vâ2 and Vâ5 (unaffected heterozygous carrier) lanes showed a 231âbp band and a 350âbp band. The P5 lane showed no band. (E) Agarose gel electrophoresis of cDNA fragments obtained from RTâPCR of P8, P10 with the c.655â2A&gt;G mutation, and the NC. The P10 lane showed a 284âbp band, which is smaller than the 350âbp band in the NC lane. The P8 lane showed a 284âbp band and a 350âbp band. (F) Agarose gel electrophoresis of cDNA fragments obtained from RTâPCR of P7, P8 with the c.439+2T&gt;A mutation, and the NC. The P7 lane showed a 263âbp band, which is smaller than the 344âbp band in the NC lane. The P8 lane showed a 263âbp band and a 344âbp band. (Gâ I) Sequence chromatogram of the RTâPCR product from P1, P10, and P7 showing exon 7 skipping and premature termination within exon 8 (G), exon 8 skipping (H), and exon 5 skipping (I) as schematically shown in the lower panel, respectively. (J) Haplotype analysis in P1 to P3. Shared haplotypes are shown in the gray box.</p>
          </caption>
          <graphic id="nlm-graphic-7" xlink:href="ANA-79-659-g004"/>
        </fig>
      </sec>
      <sec id="ana24612-sec-0022">
        <title>Clinical Features of 10 Unrelated Patients With <italic>MME</italic> Mutations</title>
        <p>P1, a 67âyearâold man born to healthy consanguineous parents, had no relevant medical history. At aged 54 years, he first noticed that his flipâflops slipped off easily because of foot drop and subsequently developed a slowly progressive gait disturbance and dysesthesia of the lower limbs. Neurological examination revealed severe weakness and atrophy of the distal limb muscles, especially the bilateral tibialis anterior muscles, which was grade 1 on the Medical Research Council scale.<xref rid="ana24612-bib-0026" ref-type="ref">26</xref> Superficial and deep sensations were decreased in the lower limbs. The cranial nerves were normal. Nerve conduction studies (NCSs) showed an axonal type of motor and sensory neuropathy: mild slowing of conduction velocity (&gt; 38 m/s) in the median and ulnar nerve, and absent motor and sensory responses in the lower extremities (Table). On the basis of these findings, he was diagnosed with an autosomal recessively inherited axonal form of CMT. He had no obvious cognitive impairment; his MMSE score was 29/30 and his cognitive subscale of the Japanese version of the Alzheimer's disease assessment scale (ADASâJâcog) score was 5/70. His brain MRI was almost normal (Fig <xref rid="ana24612-fig-0005" ref-type="fig">5</xref>A), and a PiBâPET scan did not show a significant amount of amyloid deposition (Fig <xref rid="ana24612-fig-0005" ref-type="fig">5</xref>B).</p>
        <fig fig-type="Figure" xml:lang="en" id="ana24612-fig-0005" orientation="portrait" position="float">
          <label>Figure 5</label>
          <caption>
            <p>Magnetic resonance imaging and Pittsburgh compoundâB (PiB) positron emission tomography imaging. (A) T2âweighted images of P1 showing no significant brain atrophy at 67 years of age. (B) PiB standardized uptake value (SUV) images of PiB retention in P1 at 67âyears of age and a <sup>11</sup>CâPiBâpositive Alzheimer's disease patient. Images from P1 show a lack of PiB retention throughout the gray matter and nonspecific PiB retention in the white matter compared with that of the patient with Alzheimer's disease, which shows a high retention of PiB throughout the gray matter. SUVR = standardized uptake value retention.</p>
          </caption>
          <graphic id="nlm-graphic-9" xlink:href="ANA-79-659-g005"/>
        </fig>
        <p>We summarized the clinical features and electrophysiological findings of all 10 patients in the Table. Mean age of onset of disease was 47.2 years (range, 36â56). Six of them were born to consanguineous parents (Fig <xref rid="ana24612-fig-0003" ref-type="fig">3</xref>). Clinically, all patients had slowly progressive weakness and atrophy of distal limb muscles, gait disturbance (but not yet become wheelchair dependent), sensory disturbance of the distal limbs, and decreased or absent tendon reflexes, all of which were the typical CMT phenotype. No patients showed additional neurological findings, such as pyramidal signs, cerebellar ataxia, and other CNS symptoms. NCSs showed an axonal sensorimotor neuropathy in all patients, except for P5 who was electrophysiologically diagnosed with a demyelinating/intermediate form based on delayed median nerve conduction velocities (37.4 m/s). Nine of the patients evaluated had no apparent cognitive impairment as assessed by the MMSE; all scored 26 or higher. The remaining patient had no subjective memory complaints and no clinically apparent cognitive impairment. MRI or CT scans did not show cerebral atrophy in the 5 patients evaluated.</p>
      </sec>
      <sec id="ana24612-sec-0023">
        <title>RNA Expression Analysis and Haplotype Analysis of <italic>MME</italic>
</title>
        <p>RNA analysis obtained from 6 patients (P1, P3, P5, P7, P8, and P10) and a P1 family member revealed abnormal transcripts. In P1 and P3 with the c.654+1G&gt;A mutation at the splicing donor site of intron 7 of the <italic>MME</italic> gene, agarose gel electrophoresis of the RTâPCR products obtained with primer pair 1 showed a band smaller than the 350âbp band observed in the healthy normal control (NC; Fig <xref rid="ana24612-fig-0004" ref-type="fig">4</xref>D). Sequences of the RTâPCR products in P1 and P3 revealed aberrantly spliced mRNA lacking exon 7, resulting in a 231âbp fragment (Fig <xref rid="ana24612-fig-0004" ref-type="fig">4</xref>G). The lack of exon 7 creates a frameshift and, consequently, premature termination within exon 8; therefore, the c.654+1G&gt;A mutation was designed as p.Gly179AspfsX2 at the protein level. In P5 with the c.661C&gt;T nonsense mutation, RTâPCR products were not detected (Fig <xref rid="ana24612-fig-0004" ref-type="fig">4</xref>D), suggesting the occurrence of nonsenseâmediated decay of <italic>MME</italic> mRNA. In P8 and P10 with the c.655â2A&gt;G mutation at the splicing acceptor site of intron 7, the RTâPCR products showed a smaller band than the 350âbp band of the NC (Fig <xref rid="ana24612-fig-0004" ref-type="fig">4</xref>E). The sequences of the RTâPCR products in P10 revealed aberrantly spliced mRNA lacking exon 8, resulting in a 284âbp fragment (Fig <xref rid="ana24612-fig-0004" ref-type="fig">4</xref>H). The lack of exon 8 lead to an inâframe deletion of 22 amino acids from the catalytic (extracellular) domain of NEP (p.Ile219_Glu240del). In P7 and P8 with the c.439+2T&gt;A mutation at the splicing donor site of intron 5, the RTâPCR products obtained with primer pair 2 showed a band smaller than the 344âbp band of the NC (Fig <xref rid="ana24612-fig-0004" ref-type="fig">4</xref>F). Sequences of the RTâPCR products revealed aberrantly spliced mRNA lacking exon 5, resulting in a 263âbp fragment (Fig <xref rid="ana24612-fig-0004" ref-type="fig">4</xref>I). The lack of exon 5 lead to an inâframe deletion of 27 amino acids from the catalytic domain of NEP (p.Asp120_Glu146del; Asp120Ala).</p>
        <p>Haplotype analysis in 3 patients (P1âP3) with the same homozygous c.654+1G&gt;A mutation revealed that P1 and P3, but not P2, shared the same haplotype for the two closest markers (D3S3509 and D3S1275) and four SNPs (rs12493885, rs12497267, rs9438, and rs358733; Fig <xref rid="ana24612-fig-0004" ref-type="fig">4</xref>J).</p>
      </sec>
      <sec id="ana24612-sec-0024">
        <title>Histopathological Findings and Expression of NEP</title>
        <p>An immunohistochemical assay with an antiâNEP/CD10 antibody showed expression of NEP in the germinal center of human tonsil tissue, in which NEP is highly expressed on proliferating B cells, confirming the specificity of the antibody against NEP (Fig <xref rid="ana24612-fig-0006" ref-type="fig">6</xref>A). Using this antibody, we confirmed the obvious expression of NEP in the myelin sheath of the sural nerve from the control patient, although it was also slightly expressed in the axon (Fig <xref rid="ana24612-fig-0006" ref-type="fig">6</xref>B). We obtained sural nerve biopsies from P1 and P4. Both showed a remarkable decrease in the density of large myelinated fibers with thin myelin sheaths and clusters of myelinated fibers (Fig <xref rid="ana24612-fig-0006" ref-type="fig">6</xref>C,E). Inflammatory cells and onionâbulb formation were absent. Immunohistochemical staining with an antiâNEP/CD10 antibody showed a negative and a partial positive reaction in P1 and P4, respectively, compared to myelin of the sural nerve from the control patient (Fig <xref rid="ana24612-fig-0006" ref-type="fig">6</xref>D,F). In addition, the antibody detected a band migrating at approximately 90kDa, corresponding to NEP, in the homogenates from the sural nerve of the control patient by western blotting, but the band was not detected in P1 (Fig <xref rid="ana24612-fig-0006" ref-type="fig">6</xref>G).</p>
        <fig fig-type="Figure" xml:lang="en" id="ana24612-fig-0006" orientation="portrait" position="float">
          <label>Figure 6</label>
          <caption>
            <p>Neprilysin immunohistochemistry and western blot analysis. (A) Immunohistochemical staining with an antiâNEP/CD10 antibody revealed the expression of NEP/CD10 (brown) in the marginal center of human tonsil. (B) Expression of NEP/CD10 (brown) was observed in myelin and axons, especially at the outer surface of myelin of the sural nerve from a control patient (inset). (C and E) Toluidine blue staining of a sural nerve. Densities of large myelinated fibers are markedly decreased in both patient 1 (C) and 4 (E), who harbor the c.654+1G&gt;A (p.Gly179fs) and c.1861T&gt;C (p.Cys621Arg) mutation, respectively. Clusters of small myelinated fibers are occasionally noted. (D and F) Expression of NEP/CD10 (brown) was not detected in the nerve from P1 (D), but partially detected in the nerve from P4 (F). (G) Western blot analysis of NEP/CD10. Blotted bands were detected with a rabbit antiâNEP/CD10 antibody (arrowhead). NEP/CD10 was detected in homogenates from the sural nerve of the control patient, but not P1. White bar, 100 Î¼m; black bar, 20 Î¼m. CP = control patient; MW = molecular weight marker; P1 = patient 1; Ton = human tonsil.</p>
          </caption>
          <graphic id="nlm-graphic-11" xlink:href="ANA-79-659-g006"/>
        </fig>
      </sec>
    </sec>
    <sec id="ana24612-sec-0025">
      <title>Discussion</title>
      <p>We performed WES in 303 unrelated Japanese patients with CMT among a first case series and successfully identified the <italic>MME</italic> gene as a novel ARâCMT diseaseâcausing gene using an overlapâbased strategy. After mutation screening analyses on <italic>MME</italic> in a second and third case series of unrelated patients, we finally identified mutations in the <italic>MME</italic> gene in 10 unrelated patients with CMT. WES is one of the most effective methods for identifying pathogenic mutations in Mendelian disorders.<xref rid="ana24612-bib-0027" ref-type="ref">27</xref>, <xref rid="ana24612-bib-0028" ref-type="ref">28</xref>, <xref rid="ana24612-bib-0029" ref-type="ref">29</xref> Abundant bioinformatic tools that efficiently prioritize pathogenic mutations or strategies that find diseaseâcausing genes have been developed. Three main analytical strategiesâlinkageâbased, de novoâbased, or overlapâbased strategiesâare widely used for gene research after WES.<xref rid="ana24612-bib-0030" ref-type="ref">30</xref>, <xref rid="ana24612-bib-0031" ref-type="ref">31</xref> The overlapâbased strategy helps to identify candidate genes by focusing on variants shared among multiple unrelated patients. The ESVD system we have developed based on this strategy is capable of simultaneously executing variant filtering and detecting the variants shared by disease samples and consequently contributed to the identification of the <italic>MME</italic> gene. This system could effectively identify novel causative genes in other Mendelian disorders.</p>
      <p>Our study revealed various recessive <italic>MME</italic> mutations: nonsense, missense, splice site, and deletion. The results of the RNA analysis obtained from patients with the splice site or nonsense mutations demonstrated aberrant splicing or lack of RTâPCR fragments, respectively. Moreover, we confirmed the complete absence of detectable NEP by immunohistochemical and western blotting in the sural nerve of P1 with the c.654+1G&gt;A mutation. These findings suggest that these mutations lead to a lack of NEP protein expression in the PNS attributed to a premature stop codon or nonsenseâmediated mRNA decay. Similarly, two nonsense mutations (p.Gln221X and p.Trp606X) may cause nonsenseâmediated mRNA decay. A missense mutation (p.Cys621Arg) in P4 was predicted to be damaging during in silico analysis, and cysteine 621 was highly conserved across species. Expression of NEP in the sural nerve was partially reduced. These findings suggest that this missense mutation may lead to abnormal axonal transport or fast degradation of the mutated protein. The 3âbp inâframe deletion (c.1231_1233delTGT) that eliminates cysteine at codon 411 was predicted to be deleterious using in silico analysis, and cysteine 411 was also highly conserved across species, suggesting that this deletion may affect the function of NEP. The c.439+2T&gt;A and c.655â2A&gt;G mutation causing inâframe exon skipping may lead to the large structural alterations and affect the expression and function of NEP. Taken together, our results suggest that all the recessive <italic>MME</italic> mutations in these 10 unrelated patients with CMT could be lossâofâfunction mutations, although the effects of expression and function of NEP on some mutations (c.1231_1233delTGT, c.439+2T&gt;A, and c.655â2A&gt;G) need further analysis. The result of the haplotype analysis that P1 and P3 shared the same haplotype indicates a possible ancestral founder effect for the c.654+1G&gt;A mutation. In contrast, P2 did not share this particular haplotype and an MAF of this variation in the HGVD database is 0.002 (genotype count: G/G = 299, G/A = 1, and A/A = 0), suggesting that the mutation results from independent mutational events.</p>
      <p>Clinically, all the patients with the <italic>MME</italic> mutation had a similar clinical and electrophysiological phenotype consistent with a lateâonset axonalâtype motor and sensory neuropathy. Although 1 patient (P5) had borderline motor nerve conduction velocity (NCV; 37.4 m/sec) of the median nerve between demyelinating and axonal form, we considered that his NCSs showed a primary axonal neuropathy with secondary demyelination because motor NCV of the ulnar nerve was 45.5 m/sec (&gt;38 m/sec) and compound muscle action potential (CMAP) and sensory nerve action potential (SNAP) in the lower limb nerves were not evoked. In 2 patients, larger myelinated fibers were markedly decreased in peripheral nerves, and occasionally thin myelin sheaths without onionâbulb formation were present, suggesting that the pathological process is primarily axonal degeneration.</p>
      <p>The human <italic>MME</italic> gene maps to chromosomal region 3q25.1 to q25.2, is composed of 24 exons, and is highly conserved among mammalian species.<xref rid="ana24612-bib-0032" ref-type="ref">32</xref> NEP is a type 2 MME consisting of 742 amino acids and has a molecular weight ranging from 85 to 110kDa depending on differences in its glycosylation. NEP is an ectoenzyme with the bulk of its structure, including the active site, facing the extracellular space,<xref rid="ana24612-bib-0008" ref-type="ref">8</xref> as shown Figure <xref rid="ana24612-fig-0004" ref-type="fig">4</xref>B. NEP is widely expressed in many tissues, including the nervous system,<xref rid="ana24612-bib-0033" ref-type="ref">33</xref>, <xref rid="ana24612-bib-0034" ref-type="ref">34</xref> and degrades a number of substrates such as enkephalins, substance P and atrial natriuretic peptide, and, most notably, the âAlzheimer peptide,â AÎ². Moreover, <italic>MME</italic> is also abundantly expressed in the kidney, and previous studies have suggested that <italic>MME</italic> might play a role in the normal physiological function of podocytes and was involved in various renal diseases.<xref rid="ana24612-bib-0035" ref-type="ref">35</xref>, <xref rid="ana24612-bib-0036" ref-type="ref">36</xref> However, renal failure and nephrotic syndrome were not observed in 8 patients evaluated, except for 2 who had mild proteinuria (Supplementary Table 3). These data indicated that lossâofâfunction mutations in the <italic>MME</italic> gene may be not sufficient to cause congenital renal disease.</p>
      <p>In the CNS, NEP is mainly located on neurons, particularly in the striatonigral pathway, hippocampus, and cortical regions,<xref rid="ana24612-bib-0037" ref-type="ref">37</xref>, <xref rid="ana24612-bib-0038" ref-type="ref">38</xref> and it is localized along axons and at presynaptic sites.<xref rid="ana24612-bib-0039" ref-type="ref">39</xref> These observations suggest that after synthesis in the soma, NEP is anterogradedly transported to axon terminals, where it may play an important role in neuronal function. In general, NEP knockout mice developed normally, but showed a greater sensitivity to endotoxin shock,<xref rid="ana24612-bib-0040" ref-type="ref">40</xref> elevated microvascular permeability,<xref rid="ana24612-bib-0041" ref-type="ref">41</xref> enhanced aggressive behavior, and altered locomotor activity.<xref rid="ana24612-bib-0042" ref-type="ref">42</xref> It was demonstrated that NEP knockout mice have increased levels of AÎ² peptides in the brain, and administration of the NEP inhibitor, thiorphan, to rats led to increased AÎ² levels.<xref rid="ana24612-bib-0043" ref-type="ref">43</xref>, <xref rid="ana24612-bib-0044" ref-type="ref">44</xref> Moreover, NEP knockout mice exhibited amyloidâlike deposits with signs of neurodegeneration in the hippocampus and behavioral deficits.<xref rid="ana24612-bib-0013" ref-type="ref">13</xref> These findings suggest that the decline of NEP is an important factor in the progression of Alzheimer's disease.<xref rid="ana24612-bib-0045" ref-type="ref">45</xref> In contrast, Thomas et al showed that the learning abilities were not reduced in older NEP knockout mice; rather, they were significantly improved, and AÎ² deposits could not be detected by immunohistochemical methods, in spite of the elevated AÎ² levels in the brains of these mice.<xref rid="ana24612-bib-0046" ref-type="ref">46</xref> In humans, no mutation in the <italic>MME</italic> gene linked to familial Alzheimer's disease has been reported, although some nucleotide repeat polymorphisms have been reported to be associated with susceptibility to sporadic Alzheimer's disease.<xref rid="ana24612-bib-0047" ref-type="ref">47</xref>, <xref rid="ana24612-bib-0048" ref-type="ref">48</xref> We hypothesized that human NEP deficiency would lead to cognitive impairment and increased AÎ² plaque accumulation. Contrary to our expectation, neuropsychological testing revealed no obvious cognitive deficits in 9 patients evaluated by MMSE scores. Moreover, amyloid PET imaging, which is capable of visualizing amyloid accumulation even in mild cognitive impairment or preclinical stages of Alzheimer's disease,<xref rid="ana24612-bib-0049" ref-type="ref">49</xref> was conducted and P1 showed no obvious <sup>11</sup>CâPIB retention. These clinical data indicated that lossâofâfunction mutations in the human <italic>MME</italic> gene are not sufficient to cause earlyâonset familial Alzheimer's disease, and NEP deficiency may be compensated for by other AÎ²âdegrading enzymes, such as insulinâdegrading enzyme or endothelinâconverting enzyme, in vivo.<xref rid="ana24612-bib-0011" ref-type="ref">11</xref>
</p>
      <p>In the PNS, NEP has been found in neonatal and early postnatal Schwann cells in the pig or rat sciatic nerve,<xref rid="ana24612-bib-0006" ref-type="ref">6</xref>, <xref rid="ana24612-bib-0007" ref-type="ref">7</xref> and NEP expression increased after axonal damage in adult rat Schwann cells in the sciatic nerve.<xref rid="ana24612-bib-0050" ref-type="ref">50</xref> Although there are no reports that <italic>MME</italic> mutations result in peripheral neuropathy, a previous study revealed that after chronic constriction injury of the sciatic nerve, <italic>MME</italic> knockout mice were more sensitive to heat and mechanical stimuli than were wildâtype mice, and developed edema and changes in limb temperature resembling human complex regional pain syndrome with increases in substance P and endothelin 1 in sciatic nerves.<xref rid="ana24612-bib-0051" ref-type="ref">51</xref> Interestingly, a recent study revealed the NEP is transported by anteroâ and retrograde axonal flow in rat sciatic nerves.<xref rid="ana24612-bib-0052" ref-type="ref">52</xref> In addition, our patients showed axonal neuropathy. These findings suggest that NEP could play a role in peripheral nerve development and axonal regeneration. However, as shown in Figure <xref rid="ana24612-fig-0006" ref-type="fig">6</xref>B, our immunohistochemical data revealed that NEP expression in the myelin sheath is considerably more than in the axon. For example, the mutations of peripheral myelin protein zero (<italic>MPZ</italic>) usually causes demyelinating neuropathy; however, sometimes axonal neuropathy phenotype is also shown, particularly in lateâonset form.<xref rid="ana24612-bib-0053" ref-type="ref">53</xref> In our study, given that all patients with <italic>MME</italic> mutations showed lateâonset CMT, we believe that similar degeneration process may be present in both conditions by impairing Schwann cellâaxonal interactions. Further studies are needed to clarify the role of <italic>MME</italic> in the PNS, to identify the molecular pathomechanism underlying CMT, and to develop an effective treatment for the disease.</p>
      <p>NEP has received considerable attention as a therapeutic target for Alzheimer's disease. Fortunately, Iwata et al have successfully developed a new gene delivery system by an adenoâassociated virus that can achieve comprehensive gene expression of NEP in the brain of young NEPâdeficient mice, eventually decelerating AÎ² accumulation and alleviating cognitive dysfunction.<xref rid="ana24612-bib-0054" ref-type="ref">54</xref> This gene therapy may be applied for the prevention and treatment of patients with not only Alzheimer's disease, but also CMT caused by <italic>MME</italic> mutations in the near future.</p>
      <p>Finally, we calculated the molecular diagnosis rate by only focusing on the AR mode of inheritance. Although only 17 of 77 (22%) patients received a molecular diagnosis by our microarray or NGS, the identification of the <italic>MME</italic> gene resulted in an improved molecular diagnosis rate of 35% (Fig <xref rid="ana24612-fig-0007" ref-type="fig">7</xref>). Interestingly, this result indicates that <italic>MME</italic> is the most frequent cause of ARâCMT2 in Japan.</p>
      <fig fig-type="Figure" xml:lang="en" id="ana24612-fig-0007" orientation="portrait" position="float">
        <label>Figure 7</label>
        <caption>
          <p>Rate of molecular diagnosis categorized according to inheritance modes. The upper table indicates the number of patients with molecular diagnoses by modes of inheritance in 726 patients. The pie chart below shows the rate of molecular diagnosis focused on the AR mode of inheritance. Only 17 of 77 (22%) patients received a molecular diagnosis in known CMT or IPN genes. Ten patients (13%) received a new molecular diagnosis, <italic>MME</italic> gene mutations. Rate of molecular diagnosis was increased to 35%. AR = autosomalârecessive; CMT = CharcotâMarieâTooth; IPN = inherited peripheral neuropathy.</p>
        </caption>
        <graphic id="nlm-graphic-13" xlink:href="ANA-79-659-g007"/>
      </fig>
      <p>In conclusion, for the first time, we identified <italic>MME</italic> as the most common causative gene for ARâCMT using WES followed by the ESVD system with an overlapâbased strategy. Our genetic and immunohistochemical data strongly support the finding that the <italic>MME</italic> gene is a novel causative gene for ARâCMT. All 10 patients with the <italic>MME</italic> mutation had a similar phenotype with a lateâonset axonalâtype motor and sensory neuropathy, but with no evidence of Alzheimer's disease, and we propose this new classification as ARâCMT type 2T. Identification of the <italic>MME</italic> mutations responsible for ARâCMT can improve the rate of molecular diagnosis, understanding of the molecular mechanisms of CMT, and establishment of effective therapeutic approaches.</p>
    </sec>
    <sec id="ana24612-sec-0027">
      <title>Author Contributions</title>
      <p>Y.H. and H. Takashima were responsible for conception and design of the study. Y.H. and H. Takashima; acquisition and analysis of data: All authors were responsible for acquisition and analysis of data. Y.H. was responsible for writing the manuscript.</p>
    </sec>
    <sec id="ana24612-sec-0028">
      <title>Potential Conflicts of Interest</title>
      <p>Nothing to report.</p>
    </sec>
    <sec sec-type="supplementary-material">
      <title>Supporting information</title>
      <supplementary-material content-type="local-data">
        <p>Additional supporting information can be found in the online version of this article.</p>
      </supplementary-material>
      <supplementary-material content-type="local-data">
        <caption>
          <p>Supporting Information</p>
        </caption>
        <media xlink:href="ANA-79-659-s001.docx">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
    </sec>
  </body>
  <back>
    <ack id="ana24612-sec-0026">
      <title>Acknowledgment</title>
      <p>This study was supported, in part, by grants from the research on the Nervous and Mental Disorders and Research Committee for CharcotâMarieâTooth Disease, Neuropathy, Ataxic Disease and Applying Health and Technology of Ministry of Health, Welfare and Labour, Japan. This research is also supported by the research program for conquering intractable disease from Japan Agency for Medical Research and Development (AMED).</p>
      <p>We thank Harunobu Yunokawa and Koji Suzuki of Maze Inc. for expert bioinformatics development and support, Mrs Aya Ebina and Miho Minami of our department for her excellent technical assistance, and Enago (<ext-link ext-link-type="uri" xlink:href="http://www.enago.jp">www.enago.jp</ext-link>) for the English language review. We authors thank the patients and their families for participating in this study and their physicians for submitting the clinical samples.</p>
    </ack>
    <ref-list content-type="cited-references">
      <title>References</title>
      <ref id="ana24612-bib-0001">
        <label>1</label>
        <mixed-citation publication-type="journal" id="ana24612-cit-0001">
<string-name>
<surname>Tazir</surname>
<given-names>M</given-names>
</string-name>, 
<string-name>
<surname>Bellatache</surname>
<given-names>M</given-names>
</string-name>, 
<string-name>
<surname>Nouioua</surname>
<given-names>S</given-names>
</string-name>, et al. <article-title>Autosomal recessive CharcotâMarieâTooth disease: from genes to phenotypes</article-title>. <source>J Peripher Nerv Syst</source>
<year>2013</year>;<volume>18</volume>:<fpage>113</fpage>â<lpage>129</lpage>.
<pub-id pub-id-type="pmid">23781959</pub-id></mixed-citation>
      </ref>
      <ref id="ana24612-bib-0002">
        <label>2</label>
        <mixed-citation publication-type="journal" id="ana24612-cit-0002">
<string-name>
<surname>Kabzinska</surname>
<given-names>D</given-names>
</string-name>, 
<string-name>
<surname>HausmanowaâPetrusewicz</surname>
<given-names>I</given-names>
</string-name>, 
<string-name>
<surname>Kochanski</surname>
<given-names>A</given-names>
</string-name>. <article-title>CharcotâMarieâTooth disorders with an autosomal recessive mode of inheritance</article-title>. <source>Clin Neuropathol</source>
<year>2008</year>;<volume>27</volume>:<fpage>1</fpage>â<lpage>12</lpage>.
<pub-id pub-id-type="pmid">18257469</pub-id></mixed-citation>
      </ref>
      <ref id="ana24612-bib-0003">
        <label>3</label>
        <mixed-citation publication-type="journal" id="ana24612-cit-0003">
<string-name>
<surname>Saporta</surname>
<given-names>AS</given-names>
</string-name>, 
<string-name>
<surname>Sottile</surname>
<given-names>SL</given-names>
</string-name>, 
<string-name>
<surname>Miller</surname>
<given-names>LJ</given-names>
</string-name>, et al. <article-title>CharcotâMarieâTooth disease subtypes and genetic testing strategies</article-title>. <source>Ann Neurol</source>
<year>2011</year>;<volume>69</volume>:<fpage>22</fpage>â<lpage>33</lpage>.
<pub-id pub-id-type="pmid">21280073</pub-id></mixed-citation>
      </ref>
      <ref id="ana24612-bib-0004">
        <label>4</label>
        <mixed-citation publication-type="journal" id="ana24612-cit-0004">
<string-name>
<surname>Murphy</surname>
<given-names>SM</given-names>
</string-name>, 
<string-name>
<surname>Laura</surname>
<given-names>M</given-names>
</string-name>, 
<string-name>
<surname>Fawcett</surname>
<given-names>K</given-names>
</string-name>, et al. <article-title>CharcotâMarieâTooth disease: frequency of genetic subtypes and guidelines for genetic testing</article-title>. <source>J Neurol Neurosurg Psychiatry</source>
<year>2012</year>;<volume>83</volume>:<fpage>706</fpage>â<lpage>710</lpage>.
<pub-id pub-id-type="pmid">22577229</pub-id></mixed-citation>
      </ref>
      <ref id="ana24612-bib-0005">
        <label>5</label>
        <mixed-citation publication-type="journal" id="ana24612-cit-0005">
<article-title>4th Workshop of the European CMTâConsortiumâ62nd ENMC International Workshop: rare forms of CharcotâMarieâTooth disease and related disorders 16â18 October 1998, Soestduinen, The Netherlands</article-title>. <source>Neuromuscul Disord</source>
<year>1999</year>;<volume>9</volume>:<fpage>279</fpage>â<lpage>287</lpage>.
<pub-id pub-id-type="pmid">10399758</pub-id></mixed-citation>
      </ref>
      <ref id="ana24612-bib-0006">
        <label>6</label>
        <mixed-citation publication-type="journal" id="ana24612-cit-0006">
<string-name>
<surname>Kioussi</surname>
<given-names>C</given-names>
</string-name>, 
<string-name>
<surname>Matsas</surname>
<given-names>R</given-names>
</string-name>. <article-title>Endopeptidaseâ24.11, a cellâsurface peptidase of central nervous system neurons, is expressed by Schwann cells in the pig peripheral nervous system</article-title>. <source>J Neurochem</source>
<year>1991</year>;<volume>57</volume>:<fpage>431</fpage>â<lpage>440</lpage>.
<pub-id pub-id-type="pmid">2072094</pub-id></mixed-citation>
      </ref>
      <ref id="ana24612-bib-0007">
        <label>7</label>
        <mixed-citation publication-type="journal" id="ana24612-cit-0007">
<string-name>
<surname>Kioussi</surname>
<given-names>C</given-names>
</string-name>, 
<string-name>
<surname>Crine</surname>
<given-names>P</given-names>
</string-name>, 
<string-name>
<surname>Matsas</surname>
<given-names>R</given-names>
</string-name>. <article-title>Endopeptidaseâ24.11 is suppressed in myelinâforming but not in nonâmyelinâforming Schwann cells during development of the rat sciatic nerve</article-title>. <source>Neuroscience</source>
<year>1992</year>;<volume>50</volume>:<fpage>69</fpage>â<lpage>83</lpage>.
<pub-id pub-id-type="pmid">1407560</pub-id></mixed-citation>
      </ref>
      <ref id="ana24612-bib-0008">
        <label>8</label>
        <mixed-citation publication-type="journal" id="ana24612-cit-0008">
<string-name>
<surname>Turner</surname>
<given-names>AJ</given-names>
</string-name>, 
<string-name>
<surname>Isaac</surname>
<given-names>RE</given-names>
</string-name>, 
<string-name>
<surname>Coates</surname>
<given-names>D</given-names>
</string-name>. <article-title>The neprilysin (NEP) family of zinc metalloendopeptidases: genomics and function</article-title>. <source>Bioessays</source>
<year>2001</year>;<volume>23</volume>:<fpage>261</fpage>â<lpage>269</lpage>.
<pub-id pub-id-type="pmid">11223883</pub-id></mixed-citation>
      </ref>
      <ref id="ana24612-bib-0009">
        <label>9</label>
        <mixed-citation publication-type="journal" id="ana24612-cit-0009">
<string-name>
<surname>Miners</surname>
<given-names>JS</given-names>
</string-name>, 
<string-name>
<surname>Barua</surname>
<given-names>N</given-names>
</string-name>, 
<string-name>
<surname>Kehoe</surname>
<given-names>PG</given-names>
</string-name>, et al. <article-title>Abetaâdegrading enzymes: potential for treatment of Alzheimer disease</article-title>. <source>J Neuropathol Exp Neurol</source>
<year>2011</year>;<volume>70</volume>:<fpage>944</fpage>â<lpage>959</lpage>.
<pub-id pub-id-type="pmid">22002425</pub-id></mixed-citation>
      </ref>
      <ref id="ana24612-bib-0010">
        <label>10</label>
        <mixed-citation publication-type="journal" id="ana24612-cit-0010">
<string-name>
<surname>Saido</surname>
<given-names>TC</given-names>
</string-name>. <article-title>Metabolism of amyloid beta peptide and pathogenesis of Alzheimer's disease</article-title>. <source>Proc Jpn Acad Ser B Phys Biol Sci</source>
<year>2013</year>;<volume>89</volume>:<fpage>321</fpage>â<lpage>339</lpage>.
</mixed-citation>
      </ref>
      <ref id="ana24612-bib-0011">
        <label>11</label>
        <mixed-citation publication-type="journal" id="ana24612-cit-0011">
<string-name>
<surname>Baranello</surname>
<given-names>RJ</given-names>
</string-name>, 
<string-name>
<surname>Bharani</surname>
<given-names>KL</given-names>
</string-name>, 
<string-name>
<surname>Padmaraju</surname>
<given-names>V</given-names>
</string-name>, et al. <article-title>Amyloidâbeta protein clearance and degradation (ABCD) pathways and their role in Alzheimer's disease</article-title>. <source>Curr Alzheimer Res</source>
<year>2015</year>;<volume>12</volume>:<fpage>32</fpage>â<lpage>46</lpage>.
<pub-id pub-id-type="pmid">25523424</pub-id></mixed-citation>
      </ref>
      <ref id="ana24612-bib-0012">
        <label>12</label>
        <mixed-citation publication-type="journal" id="ana24612-cit-0012">
<string-name>
<surname>Miners</surname>
<given-names>JS</given-names>
</string-name>, 
<string-name>
<surname>Van Helmond</surname>
<given-names>Z</given-names>
</string-name>, 
<string-name>
<surname>Chalmers</surname>
<given-names>K</given-names>
</string-name>, et al. <article-title>Decreased expression and activity of neprilysin in Alzheimer disease are associated with cerebral amyloid angiopathy</article-title>. <source>J Neuropathol Exp Neurol</source>
<year>2006</year>;<volume>65</volume>:<fpage>1012</fpage>â<lpage>1021</lpage>.
<pub-id pub-id-type="pmid">17021406</pub-id></mixed-citation>
      </ref>
      <ref id="ana24612-bib-0013">
        <label>13</label>
        <mixed-citation publication-type="journal" id="ana24612-cit-0013">
<string-name>
<surname>Madani</surname>
<given-names>R</given-names>
</string-name>, 
<string-name>
<surname>Poirier</surname>
<given-names>R</given-names>
</string-name>, 
<string-name>
<surname>Wolfer</surname>
<given-names>DP</given-names>
</string-name>, et al. <article-title>Lack of neprilysin suffices to generate murine amyloidâlike deposits in the brain and behavioral deficit in vivo</article-title>. <source>J Neurosci Res</source>
<year>2006</year>;<volume>84</volume>:<fpage>1871</fpage>â<lpage>1878</lpage>.
<pub-id pub-id-type="pmid">16998901</pub-id></mixed-citation>
      </ref>
      <ref id="ana24612-bib-0014">
        <label>14</label>
        <mixed-citation publication-type="journal" id="ana24612-cit-0014">
<string-name>
<surname>Zhao</surname>
<given-names>Z</given-names>
</string-name>, 
<string-name>
<surname>Hashiguchi</surname>
<given-names>A</given-names>
</string-name>, 
<string-name>
<surname>Hu</surname>
<given-names>J</given-names>
</string-name>, et al. <article-title>AlanylâtRNA synthetase mutation in a family with dominant distal hereditary motor neuropathy</article-title>. <source>Neurology</source>
<year>2012</year>;<volume>78</volume>:<fpage>1644</fpage>â<lpage>1649</lpage>.
<pub-id pub-id-type="pmid">22573628</pub-id></mixed-citation>
      </ref>
      <ref id="ana24612-bib-0015">
        <label>15</label>
        <mixed-citation publication-type="journal" id="ana24612-cit-0015">
<string-name>
<surname>Tokunaga</surname>
<given-names>S</given-names>
</string-name>, 
<string-name>
<surname>Hashiguchi</surname>
<given-names>A</given-names>
</string-name>, 
<string-name>
<surname>Yoshimura</surname>
<given-names>A</given-names>
</string-name>, et al. <article-title>Lateâonset CharcotâMarieâTooth disease 4F caused by periaxin gene mutation</article-title>. <source>Neurogenetics</source>
<year>2012</year>;<volume>13</volume>:<fpage>359</fpage>â<lpage>365</lpage>.
<pub-id pub-id-type="pmid">22847150</pub-id></mixed-citation>
      </ref>
      <ref id="ana24612-bib-0016">
        <label>16</label>
        <mixed-citation publication-type="journal" id="ana24612-cit-0016">
<string-name>
<surname>Nakamura</surname>
<given-names>T</given-names>
</string-name>, 
<string-name>
<surname>Hashiguchi</surname>
<given-names>A</given-names>
</string-name>, 
<string-name>
<surname>Suzuki</surname>
<given-names>S</given-names>
</string-name>, et al. <article-title>Vincristine exacerbates asymptomatic CharcotâMarieâtooth disease with a novel EGR2 mutation</article-title>. <source>Neurogenetics</source>
<year>2012</year>;<volume>13</volume>:<fpage>77</fpage>â<lpage>82</lpage>.
<pub-id pub-id-type="pmid">22271166</pub-id></mixed-citation>
      </ref>
      <ref id="ana24612-bib-0017">
        <label>17</label>
        <mixed-citation publication-type="journal" id="ana24612-cit-0017">
<string-name>
<surname>Hashiguchi</surname>
<given-names>A</given-names>
</string-name>, 
<string-name>
<surname>Higuchi</surname>
<given-names>Y</given-names>
</string-name>, 
<string-name>
<surname>Nomura</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>Neurofilament light mutation causes hereditary motor and sensory neuropathy with pyramidal signs</article-title>. <source>J Peripher Nerv Syst</source>
<year>2014</year>;<volume>19</volume>:<fpage>311</fpage>â<lpage>316</lpage>.
<pub-id pub-id-type="pmid">25583183</pub-id></mixed-citation>
      </ref>
      <ref id="ana24612-bib-0018">
        <label>18</label>
        <mixed-citation publication-type="journal" id="ana24612-cit-0018">
<string-name>
<surname>Li</surname>
<given-names>H</given-names>
</string-name>, 
<string-name>
<surname>Durbin</surname>
<given-names>R</given-names>
</string-name>. <article-title>Fast and accurate short read alignment with BurrowsâWheeler transform</article-title>. <source>Bioinformatics</source>
<year>2009</year>;<volume>25</volume>:<fpage>1754</fpage>â<lpage>1760</lpage>.
<pub-id pub-id-type="pmid">19451168</pub-id></mixed-citation>
      </ref>
      <ref id="ana24612-bib-0019">
        <label>19</label>
        <mixed-citation publication-type="journal" id="ana24612-cit-0019">
<string-name>
<surname>Li</surname>
<given-names>H</given-names>
</string-name>, 
<string-name>
<surname>Handsaker</surname>
<given-names>B</given-names>
</string-name>, 
<string-name>
<surname>Wysoker</surname>
<given-names>A</given-names>
</string-name>, et al. <article-title>The Sequence Alignment/Map format and SAMtools</article-title>. <source>Bioinformatics</source>
<year>2009</year>;<volume>25</volume>:<fpage>2078</fpage>â<lpage>2079</lpage>.
<pub-id pub-id-type="pmid">19505943</pub-id></mixed-citation>
      </ref>
      <ref id="ana24612-bib-0020">
        <label>20</label>
        <mixed-citation publication-type="journal" id="ana24612-cit-0020">
<string-name>
<surname>Maeda</surname>
<given-names>K</given-names>
</string-name>, 
<string-name>
<surname>Idehara</surname>
<given-names>R</given-names>
</string-name>, 
<string-name>
<surname>Hashiguchi</surname>
<given-names>A</given-names>
</string-name>, et al. <article-title>A family with distal hereditary motor neuropathy and a K141Q mutation of small heat shock protein HSPB1</article-title>. <source>Intern Med</source>
<year>2014</year>;<volume>53</volume>:<fpage>1655</fpage>â<lpage>1658</lpage>.
<pub-id pub-id-type="pmid">25088881</pub-id></mixed-citation>
      </ref>
      <ref id="ana24612-bib-0021">
        <label>21</label>
        <mixed-citation publication-type="journal" id="ana24612-cit-0021">
<string-name>
<surname>Adzhubei</surname>
<given-names>IA</given-names>
</string-name>, 
<string-name>
<surname>Schmidt</surname>
<given-names>S</given-names>
</string-name>, 
<string-name>
<surname>Peshkin</surname>
<given-names>L</given-names>
</string-name>, et al. <article-title>A method and server for predicting damaging missense mutations</article-title>. <source>Nat Methods</source>
<year>2010</year>;<volume>7</volume>:<fpage>248</fpage>â<lpage>249</lpage>.
<pub-id pub-id-type="pmid">20354512</pub-id></mixed-citation>
      </ref>
      <ref id="ana24612-bib-0022">
        <label>22</label>
        <mixed-citation publication-type="journal" id="ana24612-cit-0022">
<string-name>
<surname>Kumar</surname>
<given-names>P</given-names>
</string-name>, 
<string-name>
<surname>Henikoff</surname>
<given-names>S</given-names>
</string-name>, 
<string-name>
<surname>Ng</surname>
<given-names>PC</given-names>
</string-name>. <article-title>Predicting the effects of coding nonâsynonymous variants on protein function using the SIFT algorithm</article-title>. <source>Nat Protoc</source>
<year>2009</year>;<volume>4</volume>:<fpage>1073</fpage>â<lpage>1081</lpage>.
<pub-id pub-id-type="pmid">19561590</pub-id></mixed-citation>
      </ref>
      <ref id="ana24612-bib-0023">
        <label>23</label>
        <mixed-citation publication-type="journal" id="ana24612-cit-0023">
<string-name>
<surname>Choi</surname>
<given-names>Y</given-names>
</string-name>, 
<string-name>
<surname>Sims</surname>
<given-names>GE</given-names>
</string-name>, 
<string-name>
<surname>Murphy</surname>
<given-names>S</given-names>
</string-name>, et al. <article-title>Predicting the functional effect of amino acid substitutions and indels</article-title>. <source>PLoS One</source>
<year>2012</year>;<volume>7</volume>:<fpage>e46688</fpage>.
<pub-id pub-id-type="pmid">23056405</pub-id></mixed-citation>
      </ref>
      <ref id="ana24612-bib-0024">
        <label>24</label>
        <mixed-citation publication-type="journal" id="ana24612-cit-0024">
<string-name>
<surname>Folstein</surname>
<given-names>MF</given-names>
</string-name>, 
<string-name>
<surname>Folstein</surname>
<given-names>SE</given-names>
</string-name>, 
<string-name>
<surname>McHugh</surname>
<given-names>PR</given-names>
</string-name>. <article-title>âMiniâmental stateâ. A practical method for grading the cognitive state of patients for the clinician</article-title>. <source>J Psychiatr Res</source>
<year>1975</year>;<volume>12</volume>:<fpage>189</fpage>â<lpage>198</lpage>.
<pub-id pub-id-type="pmid">1202204</pub-id></mixed-citation>
      </ref>
      <ref id="ana24612-bib-0025">
        <label>25</label>
        <mixed-citation publication-type="journal" id="ana24612-cit-0025">
<string-name>
<surname>Rosen</surname>
<given-names>WG</given-names>
</string-name>, 
<string-name>
<surname>Mohs</surname>
<given-names>RC</given-names>
</string-name>, 
<string-name>
<surname>Davis</surname>
<given-names>KL</given-names>
</string-name>. <article-title>A new ratingâscale for alzheimersâdisease</article-title>. <source>American Journal of Psychiatry</source>
<year>1984</year>;<volume>141</volume>:<fpage>1356</fpage>â<lpage>1364</lpage>.
<pub-id pub-id-type="pmid">6496779</pub-id></mixed-citation>
      </ref>
      <ref id="ana24612-bib-0026">
        <label>26</label>
        <mixed-citation publication-type="book" id="ana24612-cit-0026">
<collab collab-type="authors">Medical Research Council</collab>
. <source>Aids to examination of the peripheral nervous system</source>. <publisher-loc>London</publisher-loc>: <publisher-name>Her Majesty's Stationary Office</publisher-name>; <year>1976</year>;<volume>45</volume>.
</mixed-citation>
      </ref>
      <ref id="ana24612-bib-0027">
        <label>27</label>
        <mixed-citation publication-type="journal" id="ana24612-cit-0027">
<string-name>
<surname>Ng</surname>
<given-names>SB</given-names>
</string-name>, 
<string-name>
<surname>Buckingham</surname>
<given-names>KJ</given-names>
</string-name>, 
<string-name>
<surname>Lee</surname>
<given-names>C</given-names>
</string-name>, et al. <article-title>Exome sequencing identifies the cause of a mendelian disorder</article-title>. <source>Nat Genet</source>
<year>2010</year>;<volume>42</volume>:<fpage>30</fpage>â<lpage>35</lpage>.
<pub-id pub-id-type="pmid">19915526</pub-id></mixed-citation>
      </ref>
      <ref id="ana24612-bib-0028">
        <label>28</label>
        <mixed-citation publication-type="journal" id="ana24612-cit-0028">
<string-name>
<surname>Ku</surname>
<given-names>CS</given-names>
</string-name>, 
<string-name>
<surname>Cooper</surname>
<given-names>DN</given-names>
</string-name>, 
<string-name>
<surname>Polychronakos</surname>
<given-names>C</given-names>
</string-name>, et al. <article-title>Exome sequencing: dual role as a discovery and diagnostic tool</article-title>. <source>Ann Neurol</source>
<year>2012</year>;<volume>71</volume>:<fpage>5</fpage>â<lpage>14</lpage>.
<pub-id pub-id-type="pmid">22275248</pub-id></mixed-citation>
      </ref>
      <ref id="ana24612-bib-0029">
        <label>29</label>
        <mixed-citation publication-type="journal" id="ana24612-cit-0029">
<string-name>
<surname>Montenegro</surname>
<given-names>G</given-names>
</string-name>, 
<string-name>
<surname>Powell</surname>
<given-names>E</given-names>
</string-name>, 
<string-name>
<surname>Huang</surname>
<given-names>J</given-names>
</string-name>, et al. <article-title>Exome sequencing allows for rapid gene identification in a CharcotâMarieâTooth family</article-title>. <source>Ann Neurol</source>
<year>2011</year>;<volume>69</volume>:<fpage>464</fpage>â<lpage>470</lpage>.
<pub-id pub-id-type="pmid">21254193</pub-id></mixed-citation>
      </ref>
      <ref id="ana24612-bib-0030">
        <label>30</label>
        <mixed-citation publication-type="journal" id="ana24612-cit-0030">
<string-name>
<surname>Gilissen</surname>
<given-names>C</given-names>
</string-name>, 
<string-name>
<surname>Hoischen</surname>
<given-names>A</given-names>
</string-name>, 
<string-name>
<surname>Brunner</surname>
<given-names>HG</given-names>
</string-name>, et al. <article-title>Disease gene identification strategies for exome sequencing</article-title>. <source>Eur J Hum Genet</source>
<year>2012</year>;<volume>20</volume>:<fpage>490</fpage>â<lpage>497</lpage>.
<pub-id pub-id-type="pmid">22258526</pub-id></mixed-citation>
      </ref>
      <ref id="ana24612-bib-0031">
        <label>31</label>
        <mixed-citation publication-type="journal" id="ana24612-cit-0031">
<string-name>
<surname>Zhang</surname>
<given-names>X</given-names>
</string-name>. <article-title>Exome sequencing greatly expedites the progressive research of Mendelian diseases</article-title>. <source>Front Med</source>
<year>2014</year>;<volume>8</volume>:<fpage>42</fpage>â<lpage>57</lpage>..
<pub-id pub-id-type="pmid">24384736</pub-id></mixed-citation>
      </ref>
      <ref id="ana24612-bib-0032">
        <label>32</label>
        <mixed-citation publication-type="journal" id="ana24612-cit-0032">
<string-name>
<surname>D'Adamio</surname>
<given-names>L</given-names>
</string-name>, 
<string-name>
<surname>Shipp</surname>
<given-names>MA</given-names>
</string-name>, 
<string-name>
<surname>Masteller</surname>
<given-names>EL</given-names>
</string-name>, et al. <article-title>Organization of the gene encoding common acute lymphoblastic leukemia antigen (neutral endopeptidase 24.11): multiple miniexons and separate 5â² untranslated regions</article-title>. <source>Proc Natl Acad Sci U S A</source>
<year>1989</year>;<volume>86</volume>:<fpage>7103</fpage>â<lpage>7107</lpage>.
<pub-id pub-id-type="pmid">2528730</pub-id></mixed-citation>
      </ref>
      <ref id="ana24612-bib-0033">
        <label>33</label>
        <mixed-citation publication-type="journal" id="ana24612-cit-0033">
<string-name>
<surname>Roques</surname>
<given-names>BP</given-names>
</string-name>, 
<string-name>
<surname>Noble</surname>
<given-names>F</given-names>
</string-name>, 
<string-name>
<surname>Dauge</surname>
<given-names>V</given-names>
</string-name>, et al. <article-title>Neutral endopeptidase 24.11: structure, inhibition, and experimental and clinical pharmacology</article-title>. <source>Pharmacol Rev</source>
<year>1993</year>;<volume>45</volume>:<fpage>87</fpage>â<lpage>146</lpage>.
<pub-id pub-id-type="pmid">8475170</pub-id></mixed-citation>
      </ref>
      <ref id="ana24612-bib-0034">
        <label>34</label>
        <mixed-citation publication-type="journal" id="ana24612-cit-0034">
<string-name>
<surname>Olerud</surname>
<given-names>JE</given-names>
</string-name>, 
<string-name>
<surname>Usui</surname>
<given-names>ML</given-names>
</string-name>, 
<string-name>
<surname>Seckin</surname>
<given-names>D</given-names>
</string-name>, et al. <article-title>Neutral endopeptidase expression and distribution in human skin and wounds</article-title>. <source>J Invest Dermatol</source>
<year>1999</year>;<volume>112</volume>:<fpage>873</fpage>â<lpage>881</lpage>.
<pub-id pub-id-type="pmid">10383732</pub-id></mixed-citation>
      </ref>
      <ref id="ana24612-bib-0035">
        <label>35</label>
        <mixed-citation publication-type="journal" id="ana24612-cit-0035">
<string-name>
<surname>Debiec</surname>
<given-names>H</given-names>
</string-name>, 
<string-name>
<surname>Nauta</surname>
<given-names>J</given-names>
</string-name>, 
<string-name>
<surname>Coulet</surname>
<given-names>F</given-names>
</string-name>, et al. <article-title>Role of truncating mutations in <italic>MME</italic> gene in fetomaternal alloimmunisation and antenatal glomerulopathies</article-title>. <source>Lancet</source>
<year>2004</year>;<volume>364</volume>:<fpage>1252</fpage>â<lpage>1259</lpage>.
<pub-id pub-id-type="pmid">15464186</pub-id></mixed-citation>
      </ref>
      <ref id="ana24612-bib-0036">
        <label>36</label>
        <mixed-citation publication-type="journal" id="ana24612-cit-0036">
<string-name>
<surname>Tong</surname>
<given-names>J</given-names>
</string-name>, 
<string-name>
<surname>Xie</surname>
<given-names>J</given-names>
</string-name>, 
<string-name>
<surname>Ren</surname>
<given-names>H</given-names>
</string-name>, et al. <article-title>Comparison of glomerular transcriptome profiles of adultâonset steroid sensitive focal segmental glomerulosclerosis and minimal change disease</article-title>. <source>PLoS One</source>
<year>2015</year>;<volume>10</volume>:<fpage>e0140453</fpage>.
<pub-id pub-id-type="pmid">26536600</pub-id></mixed-citation>
      </ref>
      <ref id="ana24612-bib-0037">
        <label>37</label>
        <mixed-citation publication-type="journal" id="ana24612-cit-0037">
<string-name>
<surname>Barnes</surname>
<given-names>K</given-names>
</string-name>, 
<string-name>
<surname>Matsas</surname>
<given-names>R</given-names>
</string-name>, 
<string-name>
<surname>Hooper</surname>
<given-names>NM</given-names>
</string-name>, et al. <article-title>Endopeptidaseâ24.11 is striosomally ordered in pig brain and, in contrast to aminopeptidase N and peptidyl dipeptidase A (âangiotensin converting enzymeâ), is a marker for a set of striatal efferent fibres</article-title>. <source>Neuroscience</source>
<year>1988</year>;<volume>27</volume>:<fpage>799</fpage>â<lpage>817</lpage>.
<pub-id pub-id-type="pmid">2908057</pub-id></mixed-citation>
      </ref>
      <ref id="ana24612-bib-0038">
        <label>38</label>
        <mixed-citation publication-type="journal" id="ana24612-cit-0038">
<string-name>
<surname>Barnes</surname>
<given-names>K</given-names>
</string-name>, 
<string-name>
<surname>Doherty</surname>
<given-names>S</given-names>
</string-name>, 
<string-name>
<surname>Turner</surname>
<given-names>AJ</given-names>
</string-name>. <article-title>Endopeptidaseâ24.11 is the integral membrane peptidase initiating degradation of somatostatin in the hippocampus</article-title>. <source>J Neurochem</source>
<year>1995</year>;<volume>64</volume>:<fpage>1826</fpage>â<lpage>1832</lpage>.
<pub-id pub-id-type="pmid">7891111</pub-id></mixed-citation>
      </ref>
      <ref id="ana24612-bib-0039">
        <label>39</label>
        <mixed-citation publication-type="journal" id="ana24612-cit-0039">
<string-name>
<surname>Fukami</surname>
<given-names>S</given-names>
</string-name>, 
<string-name>
<surname>Watanabe</surname>
<given-names>K</given-names>
</string-name>, 
<string-name>
<surname>Iwata</surname>
<given-names>N</given-names>
</string-name>, et al. <article-title>Abetaâdegrading endopeptidase, neprilysin, in mouse brain: synaptic and axonal localization inversely correlating with Abeta pathology</article-title>. <source>Neurosci Res</source>
<year>2002</year>;<volume>43</volume>:<fpage>39</fpage>â<lpage>56</lpage>.
<pub-id pub-id-type="pmid">12074840</pub-id></mixed-citation>
      </ref>
      <ref id="ana24612-bib-0040">
        <label>40</label>
        <mixed-citation publication-type="journal" id="ana24612-cit-0040">
<string-name>
<surname>Lu</surname>
<given-names>B</given-names>
</string-name>, 
<string-name>
<surname>Gerard</surname>
<given-names>NP</given-names>
</string-name>, 
<string-name>
<surname>Kolakowski</surname>
<given-names>LF</given-names>, <suffix>Jr</suffix>
</string-name>, et al. <article-title>Neutral endopeptidase modulation of septic shock</article-title>. <source>J Exp Med</source>
<year>1995</year>;<volume>181</volume>:<fpage>2271</fpage>â<lpage>2275</lpage>.
<pub-id pub-id-type="pmid">7760013</pub-id></mixed-citation>
      </ref>
      <ref id="ana24612-bib-0041">
        <label>41</label>
        <mixed-citation publication-type="journal" id="ana24612-cit-0041">
<string-name>
<surname>Lu</surname>
<given-names>B</given-names>
</string-name>, 
<string-name>
<surname>Figini</surname>
<given-names>M</given-names>
</string-name>, 
<string-name>
<surname>Emanueli</surname>
<given-names>C</given-names>
</string-name>, et al. <article-title>The control of microvascular permeability and blood pressure by neutral endopeptidase</article-title>. <source>Nat Med</source>
<year>1997</year>;<volume>3</volume>:<fpage>904</fpage>â<lpage>907</lpage>.
<pub-id pub-id-type="pmid">9256283</pub-id></mixed-citation>
      </ref>
      <ref id="ana24612-bib-0042">
        <label>42</label>
        <mixed-citation publication-type="journal" id="ana24612-cit-0042">
<string-name>
<surname>Fischer</surname>
<given-names>HS</given-names>
</string-name>, 
<string-name>
<surname>Zernig</surname>
<given-names>G</given-names>
</string-name>, 
<string-name>
<surname>Schuligoi</surname>
<given-names>R</given-names>
</string-name>, et al. <article-title>Alterations within the endogenous opioid system in mice with targeted deletion of the neutral endopeptidase (âenkephalinaseâ) gene</article-title>. <source>Regul Pept</source>
<year>2000</year>;<volume>96</volume>:<fpage>53</fpage>â<lpage>58</lpage>.
<pub-id pub-id-type="pmid">11102652</pub-id></mixed-citation>
      </ref>
      <ref id="ana24612-bib-0043">
        <label>43</label>
        <mixed-citation publication-type="journal" id="ana24612-cit-0043">
<string-name>
<surname>Iwata</surname>
<given-names>N</given-names>
</string-name>, 
<string-name>
<surname>Tsubuki</surname>
<given-names>S</given-names>
</string-name>, 
<string-name>
<surname>Takaki</surname>
<given-names>Y</given-names>
</string-name>, et al. <article-title>Identification of the major Abeta1â42âdegrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition</article-title>. <source>Nat Med</source>
<year>2000</year>;<volume>6</volume>:<fpage>143</fpage>â<lpage>150</lpage>.
<pub-id pub-id-type="pmid">10655101</pub-id></mixed-citation>
      </ref>
      <ref id="ana24612-bib-0044">
        <label>44</label>
        <mixed-citation publication-type="journal" id="ana24612-cit-0044">
<string-name>
<surname>Iwata</surname>
<given-names>N</given-names>
</string-name>, 
<string-name>
<surname>Tsubuki</surname>
<given-names>S</given-names>
</string-name>, 
<string-name>
<surname>Takaki</surname>
<given-names>Y</given-names>
</string-name>, et al. <article-title>Metabolic regulation of brain Abeta by neprilysin</article-title>. <source>Science</source>
<year>2001</year>;<volume>292</volume>:<fpage>1550</fpage>â<lpage>1552</lpage>.
<pub-id pub-id-type="pmid">11375493</pub-id></mixed-citation>
      </ref>
      <ref id="ana24612-bib-0045">
        <label>45</label>
        <mixed-citation publication-type="journal" id="ana24612-cit-0045">
<string-name>
<surname>Iwata</surname>
<given-names>N</given-names>
</string-name>, 
<string-name>
<surname>Higuchi</surname>
<given-names>M</given-names>
</string-name>, 
<string-name>
<surname>Saido</surname>
<given-names>TC</given-names>
</string-name>. <article-title>Metabolism of amyloidâbeta peptide and Alzheimer's disease</article-title>. <source>Pharmacol Ther</source>
<year>2005</year>;<volume>108</volume>:<fpage>129</fpage>â<lpage>148</lpage>.
<pub-id pub-id-type="pmid">16112736</pub-id></mixed-citation>
      </ref>
      <ref id="ana24612-bib-0046">
        <label>46</label>
        <mixed-citation publication-type="journal" id="ana24612-cit-0046">
<string-name>
<surname>Walther</surname>
<given-names>T</given-names>
</string-name>, 
<string-name>
<surname>Albrecht</surname>
<given-names>D</given-names>
</string-name>, 
<string-name>
<surname>Becker</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>Improved learning and memory in aged mice deficient in amyloid betaâdegrading neutral endopeptidase</article-title>. <source>PLoS One</source>
<year>2009</year>;<volume>4</volume>:<fpage>e4590</fpage>.
<pub-id pub-id-type="pmid">19240795</pub-id></mixed-citation>
      </ref>
      <ref id="ana24612-bib-0047">
        <label>47</label>
        <mixed-citation publication-type="journal" id="ana24612-cit-0047">
<string-name>
<surname>Clarimon</surname>
<given-names>J</given-names>
</string-name>, 
<string-name>
<surname>Munoz</surname>
<given-names>FJ</given-names>
</string-name>, 
<string-name>
<surname>Boada</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>Possible increased risk for Alzheimer's disease associated with neprilysin gene</article-title>. <source>J Neural Transm</source>
<year>2003</year>;<volume>110</volume>:<fpage>651</fpage>â<lpage>657</lpage>.
<pub-id pub-id-type="pmid">12768360</pub-id></mixed-citation>
      </ref>
      <ref id="ana24612-bib-0048">
        <label>48</label>
        <mixed-citation publication-type="journal" id="ana24612-cit-0048">
<string-name>
<surname>Helisalmi</surname>
<given-names>S</given-names>
</string-name>, 
<string-name>
<surname>Hiltunen</surname>
<given-names>M</given-names>
</string-name>, 
<string-name>
<surname>Vepsalainen</surname>
<given-names>S</given-names>
</string-name>, et al. <article-title>Polymorphisms in neprilysin gene affect the risk of Alzheimer's disease in Finnish patients</article-title>. <source>J Neurol Neurosurg Psychiatry</source>
<year>2004</year>;<volume>75</volume>:<fpage>1746</fpage>â<lpage>1748</lpage>.
<pub-id pub-id-type="pmid">15548496</pub-id></mixed-citation>
      </ref>
      <ref id="ana24612-bib-0049">
        <label>49</label>
        <mixed-citation publication-type="journal" id="ana24612-cit-0049">
<string-name>
<surname>Vlassenko</surname>
<given-names>AG</given-names>
</string-name>, 
<string-name>
<surname>Benzinger</surname>
<given-names>TL</given-names>
</string-name>, 
<string-name>
<surname>Morris</surname>
<given-names>JC</given-names>
</string-name>. <article-title>PET amyloidâbeta imaging in preclinical Alzheimer's disease</article-title>. <source>Biochim Biophys Acta</source>
<year>2012</year>;<volume>1822</volume>:<fpage>370</fpage>â<lpage>379</lpage>.
<pub-id pub-id-type="pmid">22108203</pub-id></mixed-citation>
      </ref>
      <ref id="ana24612-bib-0050">
        <label>50</label>
        <mixed-citation publication-type="journal" id="ana24612-cit-0050">
<string-name>
<surname>Kioussi</surname>
<given-names>C</given-names>
</string-name>, 
<string-name>
<surname>Mamalaki</surname>
<given-names>A</given-names>
</string-name>, 
<string-name>
<surname>Jessen</surname>
<given-names>K</given-names>
</string-name>, et al. <article-title>Expression of endopeptidaseâ24.11 (common acute lymphoblastic leukaemia antigen CD10) in the sciatic nerve of the adult rat after lesion and during regeneration</article-title>. <source>Eur J Neurosci</source>
<year>1995</year>;<volume>7</volume>:<fpage>951</fpage>â<lpage>961</lpage>.
<pub-id pub-id-type="pmid">7613630</pub-id></mixed-citation>
      </ref>
      <ref id="ana24612-bib-0051">
        <label>51</label>
        <mixed-citation publication-type="journal" id="ana24612-cit-0051">
<string-name>
<surname>Kramer</surname>
<given-names>HH</given-names>
</string-name>, 
<string-name>
<surname>He</surname>
<given-names>L</given-names>
</string-name>, 
<string-name>
<surname>Lu</surname>
<given-names>B</given-names>
</string-name>, et al. <article-title>Increased pain and neurogenic inflammation in mice deficient of neutral endopeptidase</article-title>. <source>Neurobiol Dis</source>
<year>2009</year>;<volume>35</volume>:<fpage>177</fpage>â<lpage>183</lpage>.
<pub-id pub-id-type="pmid">19084065</pub-id></mixed-citation>
      </ref>
      <ref id="ana24612-bib-0052">
        <label>52</label>
        <mixed-citation publication-type="journal" id="ana24612-cit-0052">
<string-name>
<surname>Ohkushi</surname>
<given-names>G</given-names>
</string-name>, 
<string-name>
<surname>Suzuki</surname>
<given-names>N</given-names>
</string-name>, 
<string-name>
<surname>Kobayashi</surname>
<given-names>S</given-names>
</string-name>, et al. <article-title>Axonal transport of neprilysin in rat sciatic nerves</article-title>. <source>J Mol Neurosci</source>
<year>2014</year>;<volume>53</volume>:<fpage>96</fpage>â<lpage>102</lpage>.
<pub-id pub-id-type="pmid">24362764</pub-id></mixed-citation>
      </ref>
      <ref id="ana24612-bib-0053">
        <label>53</label>
        <mixed-citation publication-type="journal" id="ana24612-cit-0053">
<string-name>
<surname>Shy</surname>
<given-names>ME</given-names>
</string-name>, 
<string-name>
<surname>Jani</surname>
<given-names>A</given-names>
</string-name>, 
<string-name>
<surname>Krajewski</surname>
<given-names>K</given-names>
</string-name>, et al. <article-title>Phenotypic clustering in MPZ mutations</article-title>. <source>Brain</source>
<year>2004</year>;<volume>127</volume>:<fpage>371</fpage>â<lpage>384</lpage>.
<pub-id pub-id-type="pmid">14711881</pub-id></mixed-citation>
      </ref>
      <ref id="ana24612-bib-0054">
        <label>54</label>
        <mixed-citation publication-type="journal" id="ana24612-cit-0054">
<string-name>
<surname>Iwata</surname>
<given-names>N</given-names>
</string-name>, 
<string-name>
<surname>Sekiguchi</surname>
<given-names>M</given-names>
</string-name>, 
<string-name>
<surname>Hattori</surname>
<given-names>Y</given-names>
</string-name>, et al. <article-title>Global brain delivery of neprilysin gene by intravascular administration of AAV vector in mice</article-title>. <source>Sci Rep</source>
<year>2013</year>;<volume>3</volume>:<fpage>1472</fpage>.
<pub-id pub-id-type="pmid">23503602</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record></GetRecord></OAI-PMH>